Search

Your search keyword '"F. Gual Capllonch"' showing total 35 results
Start Over Author "F. Gual Capllonch"
35 results on '"F. Gual Capllonch"'

1. Particle size and cholesterol content of circulating HDL correlate with cardiovascular death in chronic heart failure

Author

Albert Teis, G. Cediel, N. Amigó, J. Julve, J. Aranyó, J. Andrés-Cordón, C. Puig-Jové, E. Castelblanco, F. Gual-Capllonch, E. Ferrer-Sistach, N. Vallejo, G. Juncà, J. López-Ayerbe, M. De Antonio, M. Domingo, E. Santiago-Vacas, P. Codina, D. Mauricio, J. Lupón, Nuria Alonso, and A. Bayes-Genis

Subjects
Medicine, Science
Abstract

Abstract Evidence regarding any association of HDL-particle (HDL-P) derangements and HDL-cholesterol content with cardiovascular (CV) death in chronic heart failure (HF) is lacking. To investigate the prognostic value of HDL-P size (HDL-Sz) and the number of cholesterol molecules per HDL-P for CV death in HF patients. Outpatient chronic HF patients were enrolled. Baseline HDL-P number, subfractions and HDL-Sz were measured using 1H-NMR spectroscopy. The HDL-C/P ratio was calculated as HDL-cholesterol over HDL-P. Endpoint was CV death, with non-CV death as the competing event. 422 patients were included and followed-up during a median of 4.1 (0–8) years. CV death occurred in 120 (30.5%) patients. Mean HDL-Sz was higher in CV dead as compared with survivors (8.39 nm vs. 8.31 nm, p

Published
2021
Full Text
View/download PDF

2. Timing of cardiovascular magnetic resonance imaging and diagnostic yield in patients with acute myocardial infarction with nonobstructive coronary arteries

Author

G Junca Puig, A Teis Soley, G Kasa Yaglici, E Ferrer Sistach, J Lopez Ayerbe, N Vallejo Camazon, F Gual Capllonch, A Bayes Genis, and V Delgado Garcia

Subjects
Cardiology and Cardiovascular Medicine
Abstract

Background Accurate diagnosis of the underlying cause of myocardial infarction (MI) without obstructive coronary artery disease (MINOCA) is crucial. Cardiovascular magnetic resonance (CMR) plays an important role in the work up of patients with MINOCA. However, the timing of performance of CMR may impact on the diagnosis yield. Purpose To establish the diagnostic yield of CMR in a large cohort of patients admitted with MINOCA based on the timing of referral to CMR. Methods All patients referred to CMR from January 2009 to February 2022 with MINOCA were included. Studies were performed on a 1.5 T or 3T scanners. SSFP cines, T2-weighted black-blood fat-sat images and DE-segmented GE IR images 10–15 minutes after iv gadolinium-DTPA administration (0.15mmol/kg) were performed in 3 long-axis and 11–15 parallel short-axis views. All images were reviewed and analyzed off-line with specialized post-processing software. Results A total of 203 patients (median age 49 years, 60% men) with MINOCA diagnosis were included. Main ECG alterations were ST-segment elevation (STE) (57%) and T wave inversion (19%). Mean peak high sensitivity (HS)-TnI levels were 3706pg/mL. Median time to CMR was 7 days (5–9 days). Mean LVEF was 58% (range 18–83%) and mean LVEDVi 77 mL/m2 (range 35–210 mL/m2). Regional wall abnormalities were present in 123 patients (62%). High signal in T2w images was detected in 153 cases (75%) and late gadolinium enhancement (LGE) in 143cases (71%). Final CMR diagnosis resulted in myocarditis in 46%, MI in 20%, Takotsubo in 18%, and other cardiomyopathies in 6.4%. CMR was normal in 15 patients and not conclusive in 1. When CMR was performed within 7 days of admission (median: 5 days (4–6 days); n: 116 patients), the distribution of diagnoses was myocarditis in 53%, MI in 20%, Takotsubo in 16%, other cardiomyopathies in 6% and normal CMR in 4%. Whereas, if CMR was performed after 7 days (median: 10 days (8–12 days); n: 87 patients), the diagnoses were as flows: myocarditis in 36%, MI in 22%, Takotsubo 20%, cardiomyopathies in 7%, not conclusive in 1% and normal CMR in 13% (Table 1). Conclusions CMR led to the underlying diagnosis of MINOCA in 92% of patients. Myocarditis was the most frequent diagnosis. The final diagnosis of myocarditis was more frequent when CMR was performed within 7 days with a lesser percentage of normal CMR. Funding Acknowledgement Type of funding sources: None.

Published
2022
Full Text
View/download PDF

3. P687Is sacubitril/valsartan useful in patients with cancer and heart failure? Data from HF-COH Spanish multicenter registry

Author

J L Lopez Sendon, M Antunez Ballesteros, Pedro Moliner, Pedro L. Sánchez, Cristina Mitroi, Ana Martín-García, Teresa López-Fernández, A C Martin Garcia, C Asla, F Gual-Capllonch, C Sanchez-Pablo, A Martinez-Monzonis, Almudena Castro, I Marco, and M. Chaparro

Subjects
medicine.medical_specialty, business.industry, Internal medicine, Heart failure, medicine, Cancer, In patient, Cardiology and Cardiovascular Medicine, medicine.disease, business, Sacubitril, Valsartan
Abstract

Current guidelines recommend sacubitril/valsartan (S/V) for patients (p.) with heart failure and reduced left ventricular ejection fraction (LVEF) but there is lack of evidence of its efficacy and safety in p. with cancer and heart failure. Our aim was to analyze the potential benefit of S/V in specific cardio-oncology clinics. Methods We performed a retrospective multicenter registry (HF-COH) in six Spanish hospitals with cardio-oncology clinics including all p. treated with S/V. Clinical and echocardiographic data, NYHA functional class, type of neoplasms and anti-tumoral treatment were described. Median follow-up was 7.2 [7.9] months. Results Sixty-one p. were included (median age was 64 [21] years old; 64%women, 43% hypertensive, 54% dyslipidemics and 28% diabetics). Most of p. (97%) had cancer therapy related cardiac dysfunction (CTRD) with a median time from anti-cancer therapy to CTRD of 40 [132] months. Breast (46%) and hematological (38%) cancers were the most frequent neoplasms, 31% of p. had metastatic disease and 71% had been treated with anthracyclines. In 5% S/V was initiated at CTRCD diagnosis while in 95% S/V was started to improve clinical status in p. already treated with ACE inhibitors or ARBs. 87% were on beta-blocker therapy and 74% on mineralocorticoid receptor antagonists.Maximal S/V titration dose was achieved in 8.2% of p. (24/26mg: 43%; 49/51mg: 33%) S/V was discontinued in 4 p. (reasons: 2 hypotension; 1: renal failure; 1: pruritus) Baseline NT-proBNP levels, functional class, and LVEF improved at the end of follow-up in p. who continued with S/V (all p values ≤0.01). No statistical differences were found in creatinine clearance or potassium serum levels. Table Patient parameters before and after S/V Before S/V After S/V P value LVEF (%) 33 [7] 39.5 [15] Conclusions Our experience suggests that S/V is well tolerated and improves functional class and left ventricular function parameters in patients with CTRCD.

Published
2019
Full Text
View/download PDF

4. Club 35 Poster Session Wednesday 5 December * Right ventricular systolic function

Author

T. Hugues, V. Lacroix-Hugues, K. Yaici, P. Gibelin, I. Cabrita, S. Pires, A. Nunes, C. Sousa, N. Cortez-Dias, F. Pinto, A. Hrynkiewicz-Szymanska, W. Braksator, F. Szymanski, M. Chmielewski, M. Dluzniewski, P. Alonso Fernandez, A. Andres Lahuerta, V. Miro Palau, F. Buendia Fuentes, B. Igual Munoz, A. Osa Saez, A. Quesada Carmona, D. Tejada Ponce, B. Munoz, A. Salvador Sanz, S. Imamura, K. H. Hirata, T. Kubo, M. Orii, T. Tanimono, K. Takemoto, Y. Ino, T. Yamaguchi, T. Imanishi, T. Akasaka, T. Kinoshita, T. Asai, T. Suzuki, M. Krestjyaninov, V. Ruzov, T. Tanimoto, T. Yamano, G. Junca Puig, E. F. Sistach, L. Delgado Ramis, J. Lopez Ayerbe, N. Vallejo Camazon, f. Gual Capllonch, A. Teis Soley, M. Camara Rosell, X. Ruyra Baliarda, A. Bayes-Genis, P. Alonso fernandez, A. Maceira Gonzalez, C. Hernandez, A. Bel Minguez, B. Munoz Igual, A. Montero Argudo, S. Antit, S. fennira, I. Zairi, S. Kamoun, S. Kraiem, A. Matsuyama, C. Van De Heyning, J. Magne, L. Pierard, L. Davin, P. Bruyere, C. De Maeyer, B. Paelinck, C. Vrints, P. Lancellotti, J. Wang, f. fang, M. Liu, Y. Liang, C. Yu, Y. Lam, C. Kenny, M. Monaghan, S. Ercan, S. Kervancioglu, V. Davutoglu, M. Cakici, A. Ozkur, M. Oylumlu, I. Sari, A. Sikora-Puz, M. Mizia, K. Gieszczyk-Strozik, K. Matyjaszczyk-Zbieg, M. Haberka, K. Mizia-Stec, Z. Gasior, S. Wos, M. Deja, M. Jasinski, O. Enescu, M. florescu, D. Mihalcea, R. Rimbas, M. Cinteza, and D. Vinereanu

Subjects
medicine.medical_specialty, business.industry, Physical therapy, medicine, Radiology, Nuclear Medicine and imaging, General Medicine, Session (computer science), Systolic function, Club, Cardiology and Cardiovascular Medicine, business
Published
2012
Full Text
View/download PDF

5. Poster Session 3: Friday 9 December 2011, 08:30-12:30 * Location: Poster Area

Author

C. Kenny, S. Adhya, R. Dworakowski, B. Brickham, P. Maccarthy, M. Monaghan, A. Guzzo, F. Innocenti, S. Vicidomini, D. Lazzeretti, S. Squarciotta, E. De Villa, C. Donnini, F. Bulletti, E. Guerrini, R. Pini, K. Bendjelid, J. Viale, S. Duperret, V. Piriou, D. Jacques, K. Shahgaldi, C. Silva, F. Pedro, L. Deister, L.-A. Brodin, A. Sahlen, A. Manouras, R. Winter, N. Berjeb, C. Cimadevilla, J. Dreyfus, C. Cueff, M. Malanca, A. Chiampan, A. Vahanian, D. Messika-Zeitoun, D. Muraru, D. Peluso, L. Dal Bianco, M. Beraldo, E. Solda', M. Tuveri, U. Cucchini, A. Al Mamary, L. Badano, S. Iliceto, I. Almuntaser, G. King, S. Norris, C. Daly, E. Ellis, R. Murphy, T. Erdei, M. Denes, A. Kardos, C. Foldesi, A. Temesvari, M. Lengyel, A. Bouzas Mosquera, F. Broullon, N. Alvarez-Garcia, J. Peteiro, G. Barge-Caballero, M. Lopez-Perez, A. Lopez-Sainz, A. Castro-Beiras, M. Luotolahti, H. Luotolahti, I. Kantola, J. Viikari, M. Andersen, M. Ersboell, J. Bro-Jeppesen, F. Gustafsson, L. Koeber, C. Hassager, J. Moller, D. Coisne, C. Diakov, F. Vallet, B. Lequeux, P. Blouin, L. Christiaens, R. Esposito, A. Santoro, V. Schiano Lomoriello, R. Raia, C. Santoro, G. De Simone, M. Galderisi, G. Abdula, W. Kosmala, H. Szczepanik-Osadnik, M. Przewlocka-Kosmala, A. Mysiak, T. O' Moore-Sullivan, T. Marwick, Y. T. Tan, F. Wenzelburger, F. Leyva, J. Sanderson, P. Pichler, B. Syeda, P. Hoefer, A. Zuckermann, T. Binder, M. Fijalkowski, A. Koprowski, R. Galaska, K. Blaut, K. Sworczak, A. Rynkiewicz, S. Lee, W. Kim, L. Jung, H. Yun, M. Song, J. Ko, E. A. Khalifa, P. Szymanski, M. Lipczynska, A. Klisieiwcz, P. Hoffman, C. Jorge, J. Silva Marques, S. Robalo Martins, C. Calisto, M. Mieiro, S. Vieira, M. Correia, J. Carvalho De Sousa, A. Almeida, A. Nunes Diogo, C. Park, K. March, T. Tillin, J. Mayet, N. Chaturvedi, A. Hughes, V. Di Bello, C. Giannini, M. Delle Donne, F. De Sanctis, P. Spontoni, C. Cucco, A. Corciu, C. Grigoratos, F. Bogazzi, A. Balbarini, O. Enescu, B. Suran, M. Florescu, M. Cinteza, D. Vinereanu, Y. Higuchi, K. Iwakura, A. Okamura, M. Date, K. Fujii, N. Cortez-Dias, D. Silva, P. Carrilho-Ferreira, A. Magalhaes, S. Ribeiro, S. Goncalves, M. Fiuza, F. Pinto, R. Placido, A. Bordalo, P. Grzywocz, K. Mizia-Stec, J. Chudek, Z. Gasior, A. M. Maceira Gonzalez, J. Cosin Sales, E. Dalli, B. Igual, J. Diago, J. Aguilar, J. Ruvira, S. Cimino, G. Pedrizzetti, G. Tonti, E. Canali, V. Petronilli, F. Boccalini, A. Mattatelli, Y. Hiramoto, C. Iacoboni, L. Agati, D. Trifunovic, M. Ostojic, B. Vujisic-Tesic, M. Petrovic, I. Nedeljkovic, M. Banovic, M. Boricic-Kostic, G. Draganic, M. Tesic, C. Gavina, R. Lopes, A. Lourenco, J. Almeida, J. Rodrigues, P. Pinho, J. Zamorano, A. Leite-Moreira, F. Rocha-Goncalves, M.-A. Clavel, R. Capoulade, J. Dumesnil, P. Mathieu, J.-P. Despres, P. Pibarot, S. Bull, A. Pitcher, D. Augustine, J. D'arcy, T. Karamitsos, A. Rai, B. Prendergast, H. Becher, S. Neubauer, S. Myerson, J. Magne, E. Donal, L. Davin, K. O'connor, C. Pirlet, M. Rosca, C. Szymanski, B. Cosyns, L. Pierard, P. Lancellotti, A. Calin, B. Popescu, C. Beladan, R. Enache, L. Lupascu, C. Sandu, C. Ginghina, V. Kamperidis, S. Hadjimiltiadis, G. Sianos, K. Anastasiadis, V. Grosomanidis, G. Efthimiadis, H. Karvounis, G. Parharidis, I. Styliadis, C. Gonzalez Canovas, C. Munoz-Esparza, J. Bonaque Gonzalez, A. Fernandez, M. Salar Alcaraz, D. Saura Espin, E. Pinar Bermudez, M. Oliva-Sandoval, G. De La Morena Valenzuela, M. Valdes Chavarri, E. Brochet, L. Lepage, D. Attias, D. Detaint, D. Himbert, B. Iung, B. Pirat, S. Little, S. Chang, L. Tiller, R. Kumar, W. Zoghbi, A. P.-W. Lee, M. Hsiung, S. Wan, R. Wong, F. Luo, F. Fang, J. Xie, M. Underwood, J. Sun, C. Yu, R. Jansen, W. Tietge, K. Sijbrandij, M. Cramer, L. De Heer, J. Kluin, S. A. J. Chamuleau, T. Oliveras Vila, E. Ferrer Sistach, L. Delgado Ramis, J. Lopez Ayerbe, N. Vallejo Camazon, F. Gual Capllonch, C. Garcia Alonso, A. Teis Soley, X. Ruyra Baliarda, A. Bayes Genis, S. Negrea, C. Alexandrescu, F. Bourlon, F. Civaia, G. Dreyfus, S. Paetzold, O. Luha, R. Hoedl, G. Stoschitzky, K. Pfeiffer, D. Zweiker, B. Pieske, R. Maier, T. Sevilla, A. Revilla, J. Lopez, I. Vilacosta, R. Arnold, I. Gomez, J. San Roman, G. Nikcevic, A. Djordjevic Dikic, S. Djordjevic, S. Raspopovic, V. Jovanovic, B. Kircanski, S. Pavlovic, G. Milasinovic, I. Ruiz-Zamora, F. Cabrera Bueno, M. Molina, J. Fernandez-Pastor, J. Pena, A. Linde, A. Barrera, J. Alzueta, C. Bremont, A. Bensaid, H. Alonso, O. Zaghden, J. Nahum, J. Dubois-Rande, P. Gueret, P. Lim, S.-P. Lee, K. Park, H.-R. Kim, J.-H. Lee, H.-S. Ahn, J.-H. Kim, H.-K. Kim, Y.-J. Kim, D.-W. Sohn, M. Niemann, S. Herrmann, K. Hu, D. Liu, M. Beer, G. Ertl, C. Wanner, T. Takenaka, C. Tei, F. Weidemann, H. Madeira, M. Mendes Pedro, D. Brito, R. Ippolito, D. De Palma, S. Gati, D. Oxborough, M. Reed, A. Zaidi, S. Ghani, N. Sheikh, M. Papadakis, S. Sharma, V. Chow, A. Ng, T. Pasqualon, W. Zhao, D. Hanzek, T. Chung, T. Yeoh, L. Kritharides, L. Magda, D. Mihalcea, D. Jinga, R. Mincu, E. Ferrazzi, G. Segato, F. Folino, G. Famoso, M. Senzolo, R. Bellu, F. Corbetti, F. Tona, O. Azevedo, I. Quelhas, J. Guardado, M. Fernandes, V. Pereira, R. Medeiros, P. Sousa, W. Santos, S. Pereira, N. Marques, J. Mimoso, V. Marques, I. Jesus, L. Rustad, K. Nytroen, L. Gullestad, B. Amundsen, S. Aakhus, K. Linhartova, G. Sterbakova, J. Necas, S. Kovalova, R. Cerbak, N. Nelassov, N. Korotkijan, A. Shishkina, B. Gagieva, M. Nagaplev, O. Eroshenko, M. Morgunov, S. Parmon, S. Velthuis, M. Van Gent, M. Post, C. Westermann, J. Mager, R. Snijder, S. P. Koyalakonda, M. Anderson, M. Burgess, L. Bergenzaun, M. Chew, H. Ohlin, G. F. Gjerdalen, J. Hisdal, E. Solberg, T. Andersen, Z. Radunovic, K. Steine, T. Rutz, A. Kuehn, K. Petzuch, M. Pekala, J. Elmenhorst, S. Fratz, J. Mueller, A. Hager, J. Hess, M. Vogt, D. Van Der Linde, I. Van De Laar, M. Wessels, J. Bekkers, A. Moelker, H. Tanghe, F. Van Kooten, R. Oldenburg, A. Bertoli-Avella, J. Roos-Hesselink, A. Cresti, L. Fontani, P. Calabria, E. Capati, S. Severi, M. Lynch, S. Saraf, B. Sandler, S. Yoon, S. Kim, C. Ko, S. Ryu, Y. Byun, H. Seo, Q. Ciampi, F. Rigo, L. Pratali, S. Gherardi, B. Villari, E. Picano, R. Sicari, J. Celutkiene, D. Zakarkaite, V. Skorniakov, V. Zvironaite, V. Grabauskiene, J. Sinicyna, G. Gruodyte, K. Janonyte, A. Laucevicius, J. O'driscoll, K. Schmid, A. Marciniak, A. Saha, S. Gupta, R. Smith, R. Sharma, N. Alvarez Garcia, O. Prada, A. Rodriguez Vilela, G. Barge Caballero, M. Lopez Perez, A. Lopez Sainz, A. Castro Beiras, J. Kochanowski, P. Scislo, R. Piatkowski, M. Grabowski, M. Marchel, M. Roik, D. Kosior, G. Opolski, C. M. Van De Heyning, H. Mahjoub, H. Clausen, C. Basaggianis, J. Newton, A. Del Pasqua, A. Carotti, D. Di Carlo, E. Cetrano, A. Toscano, R. Iacobelli, C. Esposito, M. Chinali, G. Pongiglione, G. Rinelli, M. Larsson, A. Bjallmark, K. Caidahl, L. Brodin, H. Gao, M. Lugiez, C. Guivier, R. Rieu, J. D'hooge, G. Hang, C. Guerin, M. Menard, J.-U. Voigt, J. Dungu, G. Campos, R. Jaffarulla, S. Gomes-Pereira, N. Sutaria, C. Baker, P. Nihoyannopoulos, M. Bellamy, D. Harries, N. Walker, P. Pearson, J. Reiken, J. Batteson, R. Kamdar, F. Murgatroyd, A. D'andrea, L. Riegler, R. Scarafile, E. Pezzullo, G. Salerno, E. Bossone, G. Limongelli, M. Russo, G. Pacileo, R. Calabro', Y. Kang, J. Cui, H. Chen, C. Pan, X. Shu, A. Kiotsekoglou, S. Saha, R. Toole, S. Govind, A. Gopal, F. Crispi, B. Bijnens, E. Sepulveda-Swatson, J. Rojas-Benavente, J. Dominguez, M. Illa, E. Eixarch, M. Sitges, E. Gratacos, C. Prinz, R. Faludi, A. Walker, M. Amzulescu, T. Uejima, A. Fraser, J. Voigt, M. Esmaeilzadeh, M. Maleki, A. Amin, F. Vakilian, F. Noohi, Z. Ojaghi Haghighi, P. Nakhostin Davari, H. Bakhshandeh Abkenar, R. Rimbas, R. Dulgheru, A. Margulescu, M. D' Asaro, C. Mizzon, F. Parisi, B.-C. Jung, B.-Y. Lee, H.-J. Kang, M. Kim, Y. Kim, D. Cho, S. Park, S. Hong, D. Lim, W. Shim, H. Bellsham-Revell, S. Tibby, A. J. Bell, O. I. Miller, G. Greil, J. M. Simpson, R. A. Providencia, J. Trigo, A. Botelho, P. Gomes, L. Seca, S. Barra, A. Faustino, G. Costa, N. Quintal, A. Leitao-Marques, E. Nestaas, A. Stoylen, D. Fugelseth, C. Mornos, A. Ionac, L. Petrescu, D. Cozma, D. Dragulescu, A. Mornos, S. Pescariu, A. Fontana, M. Abbate, M. Cazzaniga, C. Giannattasio, G. Trocino, K. Laser, L. Faber, M. Fischer, H. Koerperich, D. Kececioglu, M. F. Elnoamany, A. Dawood, M. Elhabashy, Y. Khalil, N. Piriou, K. Warin-Fresse, M. Caza, G. Fau, D. Crochet, N. Xhabija, I. Allajbeu, E. Petrela, M. Heba, M. Barreiro Perez, M. Martin Fernandez, A. Renilla Gonzalez, J. Florez Munoz, O. Fernandez Cimadevilla, I. Alvarez Pichel, E. Velasco Alonso, D. Leon Duran, E. Benito Martin, S. Secades Gonzalez, L. Gargani, P. Pang, E. Davis, A. Schumacher, A. Silva Ferreira, N. Bettencourt, P. Matos, L. Oliveira, J. Cosin-Sales, M. Lopez Lereu, J. Monmeneu, J. Estornell, M. Tsverava, D. Tsverava, A. Varela, M. Salagianni, I. Galani, E. Andreakos, C. Davos, I. Ikonomidis, J. Lekakis, V. Tritakis, N. Kadoglou, J. Papadakis, P. Trivilou, S. Tzortzis, C. Koukoulis, I. Paraskevaidis, M. Anastasiou-Nana, G. Kim, H. Youn, P. Ibrahimi, G. Bajraktari, F. Jashari, A. Ahmeti, A. Poniku, E. Haliti, M. Henein, B. Pezo Nikolic, H. Jurin, D. Lovric, Z. Baricevic, I. Ivanac Vranesic, M. Lovric Bencic, A. Ernst, and J. Separovic Hanzevacki

Subjects
Novel technique, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Computer vision, Nanotechnology, General Medicine, Contrast (music), Artificial intelligence, Cardiology and Cardiovascular Medicine, business
Published
2011
Full Text
View/download PDF

6. Poster Session 2: Thursday 8 December 2011, 14:00-18:00 * Location: Poster Area

Author

X. Luo, F. Fang, J. Sun, J. Xie, A. Lee, Q. Zhang, C. Yu, O. Breithardt, S. Schiessl, M. Schmid, M. Seltmann, L. Klinghammer, C. Zeissler, M. Kuechle, W. Daniel, M. Ege, U. Guray, Y. Guray, B. Demirkan, H. Kisacik, S.-E. Kim, J.-Y. Hong, J.-H. Lee, D.-G. Park, K.-R. Han, D.-J. Oh, O. Tufekcioglu, D. C. Cozma, C. Mornos, A. Ionac, L. Petrescu, C. Tutuianu, S. I. Dragulescu, L. Guimaraes, G. Tavares, A. Rodrigues, C. Nagamatsu, C. Fischer, M. Vieira, W. Oliveira, T. Wilberg, A. Cordovil, S. Morhy, D. Muraru, M. Peluso, L. Dal Bianco, M. Beraldo, E. Solda', M. Tuveri, U. Cucchini, A. Al Mamary, L. Badano, S. Iliceto, A. Pizzuti, B. Mabritto, C. Derosa, A. Tomasello, M. Rovere, I. Parrini, M. Conte, N. Lareva, A. Govorin, R. Cooper, J. Sharif, J. D. Somauroo, J. D. Hung, V. Porcelli, R. Skevington, A. Shahzad, S. Scott, P. Lindqvist, S. Soderberg, M. Gonzalez, E. Tossavainen, M. Henein, N. Nciri, H. Saad, S. Nawas, A. Ali, A. Youssufzay, A. Safi, S. Faruk, S. Yurdakul, V. Erdemir, Y. Tayyareci, O. Yildirimturk, K. Memic, V. Aytekin, M. Gurel, S. Aytekin, M. Przewlocka-Kosmala, M. Cielecka-Prynda, A. Mysiak, W. Kosmala, S. Pescariu, D. Cozma, A. Mornos, S. Dragulescu, N. Maurea, C. G. Tocchetti, C. Coppola, C. Quintavalle, D. Rea, A. Barbieri, G. Piscopo, C. Arra, G. Condorelli, R. Iaffaioli, H. Dalen, A. Thorstensen, H. Moelmen, H. Torp, A. Stoylen, D. Augustine, C. Basagiannis, J. Suttie, P. Cox, R. Aitzaz, A. Lewandowski, M. Lazdam, C. Holloway, H. Becher, P. Leeson, S. Radovanovic, A. Djokovic, B. Todic, M. Zdravkovic, M. Zaja-Simic, S. Banicevic, D. Lisulov-Popovic, M. Krotin, J. Grapsa, D. O'regan, D. Dawson, G. Durighel, L. Howard, J. Gibbs, P. Nihoyannopoulos, C. Tulunay Kaya, M. Kilickap, H. Kurklu, N. Ozbek, C. Koca, V. Kozluca, K. Esenboga, C. Erol, B. Kusmierczyk-Droszcz, E. Kowalik, J. Niewiadomska, P. Hoffman, M. Satendra, L. Sargento, S. Lopes, S. Longo, N. Lousada, R. Palma Reis, P. Chillo, A. Rieck, J. Lwakatare, J. Lutale, E. Gerdts, S. Bonapace, G. Molon, G. Targher, A. Rossi, L. Lanzoni, G. Canali, E. Campopiano, L. Zenari, L. Bertolini, E. Barbieri, K. Hristova, L. Vladiomirova-Kitova, T. Katova, F. Nikolov, P. Nikolov, S. Georgieva, I. Simova, V. Kostova, V. A. Kuznetsov, D. V. Krinochkin, P. A. Chandraratna, Y. A. Pak, E. H. Zakharova, A. V. Plusnin, M. V. Semukhin, E. A. Gorbatenko, E. I. Yaroslavskaya, G. Bedetti, L. Gargani, M. Scalese, C. Pizzi, R. Sicari, E. Picano, M. Reali, E. Canali, S. Cimino, M. Francone, M. Mancone, R. Scardala, F. Boccalini, Y. Hiramoto, A. Frustaci, L. Agati, K. Savino, A. Lilli, E. Bordoni, C. Riccini, G. Ambrosio, D. Silva, N. Cortez-Dias, P. Carrilho-Ferreira, C. Jorge, J. Silva-Marques, A. Magalhaes, L. Santos, S. Ribeiro, F. Pinto, A. Nunes Diogo, E. Kinova, N. Zlatareva, A. Goudev, C. Bonanad, M. Lopez-Lereu, J. Monmeneu, V. Bodi, J. Sanchis, J. Nunez, F. Chaustre, A. Llacer, D. Ermacora, D. Peluso, M. Di Lazzari, P. Meimoun, F. Elmkies, T. Benali, J. Boulanger, H. Zemir, J. Clerc, A. Luycx-Bore, M. S. Velasco Del Castillo, A. Cacicedo Fernandez De Bobadilla, J. Onaindia Gandarias, M. Telleria Arrieta, G. Zugazabeitia Irazabal, O. Quintana Raczka, I. Rodriguez Sanchez, A. Romero Pereiro, E. Laraudogoitia Zaldumbide, I. Lekuona Goya, B. Bonello, E. El Louali, V. Fouilloux, I. Kammache, C. Ovaert, B. Kreitmann, A. Fraisse, R. Migliore, M. Adaniya, M. Barranco, G. Miramont, H. Tamagusuku, A. Alassar, R. Sharma, A. Marciniak, O. Valencia, N. Abdulkareem, M. Jahangiri, N. Jander, R. Kienzle, C. Gohlke-Baerwolf, H. Gohlke, F.-J. Neumann, J. Minners, S. Valbuena, F. De Torres, T. Lopez, J. J. Gomez, G. Guzman, F. Dominguez, E. Refoyo, M. Moreno, J. L. Lopez-Sendon, R. Ancona, S. Comenale Pinto, P. Caso, G. Di Salvo, S. Severino, M. Cavallaro, R. Calabro, R. Enache, R. Piazza, A. Roman-Pognuz, B. Popescu, A. Calin, C. Beladan, F. Purcarea, G. Nicolosi, C. Ginghina, O. Savu, M. Rosca, R. Jurcut, M. Serban, L. Dorobantu, E. Donal, S. Mascle, C. Thebault, D. Veillard, H. Hamonic, A. Leguerrier, H. Corbineau, B. A. Popa, M. Diena, A. Bogdan, D. Benea, G. Lanzillo, V. Casati, E. Novelli, A. Popa, G. Cerin, F. Gual Capllonch, A. Teis, J. Lopez Ayerbe, E. Ferrer, N. Vallejo, E. Gomez Denia, A. Bayes Genis, S. Spethmann, S. Schattke, G. Baldenhofer, V. Stangl, M. Laule, G. Baumann, K. Stangl, F. Knebel, C. Labata, C. Garcia Alonso, F. Gual, R. Nunez Aragon, C. Sousa, A. I. Vasile, M. Dorobantu, C. Iorgulescu, S. Bogdan, D. Constantinescu, C. Caldararu, O. Tautu, R. Vatasescu, H. Badran, M. F. Elnoamany, M. Ayad, A. Elshereef, A. Farhan, Y. Nassar, M. Yacoub, J. Costabel, G. Avegliano, P. Elissamburu, J. Thierer, F. Castro, M. Huguet, A. Frangi, R. Ronderos, C. Prinz, F. Van Buuren, L. Faber, T. Bitter, N. Bogunovic, W. Burchert, D. Horstkotte, J. D. Kasprzak, A. Smialowski, T. Rudzinski, P. Lipiec, M. Krzeminska-Pakula, K. Wierzbowska-Drabik, E. Trzos, M. Kurpesa, H. Motoki, M. Hana, T. Marwick, K. Allan, M. Vazquez-Alvarez, C. Medrano Lopez, S. Granja Da Silva, C. Marcos, A. Rodriguez-Ogando, M. Alvarez, M. Camino, M. Centeno, E. Maroto, G. Feltes Guzman, V. Serra Tomas, O. Acevedo, A. Calli, M. Barba, G. Pintos, V. Valverde, J. Zamorano Gomez, M. Marchel, J. Kochanowski, R. Piatkowski, A. Madej, K. Filipiak, I. Hausmanowa-Petrusewicz, G. Opolski, E. Malev, E. Zemtsovsky, S. Reeva, E. Timofeev, A. Pshepiy, S. Mihaila, R. Rimbas, R. Mincu, R. Dulgheru, R. Mihaila, C. Badiu, M. Cinteza, D. Vinereanu, E. Lira, D. Lebihan, C. Monaco, M. Ruiz Ortiz, D. Mesa, M. Delgado, E. Romo, M. Pena, M. Puentes, M. Santisteban, A. Lopez Granados, J. Arizon Del Prado, J. Suarez De Lezo, W.-C. Tsai, J.-Y. Shih, T.-S. Huang, Y.-W. Liu, Y.-Y. Huang, L.-M. Tsai, E. Cho, K. Choi, B. Kwon, D. Kim, S. Jang, C. Park, H. Jung, H. Jeon, H. Youn, J. Kim, A. E. Rieck, D. Cramariuc, M. Lonnebakken, B. Lund, P. Moceri, D. Doyen, P. Cerboni, E. Ferrari, W. Li, S. Goncalves, G. Vinhais De Sousa, A. G. Almeida, C. Hernandez Garcia, A. De La Rosa Hernandez, E. Arroyo Ucar, P. Jorge Perez, A. Barragan Acea, J. Lacalzada Almeida, J. Jimenez Rivera, A. Duque Garcia, I. Laynez Cerdena, O. Arhipov, A. N. Sumin, L. Campens, M. Renard, B. Trachet, P. Segers, A. De Paepe, J. De Backer, J. A. Purvis, D. Sharma, S. M. Hughes, D. Marek, D. Vindis, E. Kocianova, M. Taborsky, H. Yoon, K. Kim, Y. Ahn, M. Chung, J. Cho, J. Kang, W. Rha, O. Ozcan, D. Sezgin Ozcan, B. Candemir, M. Aras, I. Dincer, R. Atak, L. Gianturco, M. Turiel, F. Atzeni, L. Tomasoni, E. Bruschi, O. Epis, P. Sarzi-Puttini, C. Aggeli, E. Poulidakis, I. Felekos, S. Sideris, P. Dilaveris, K. Gatzoulis, C. Stefanadis, N. Roszczyk, M. Sobczak, J. Peruga, R. Krecki, J. Kasprzak, K. Ishii, T. Suyama, K. Kataoka, A. Furukawa, T. Nagai, M. Maenaka, Y. Seino, F. Musca, B. De Chiara, A. Moreo, S. Cataldo, M. Parolini, O. Parodi, T. Bombardini, F. Faita, S.-J. Park, J.-H. Kil, S.-J. Kim, S.-Y. Jang, S.-A. Chang, J.-O. Choi, S.-C. Lee, S. Park, P. Park, J. Oh, M. Cikes, V. Velagic, B. Biocina, H. Gasparovic, Z. Djuric, B. Bijnens, D. Milicic, A. Huqi, B. Klas, A. He, I. Paterson, M. Irween, J. Ezekovitz, J. Choy, Y. Chen, L. Cheng, R. Yao, H. Yao, H. Chen, C. Pan, X. Shu, B. Sobkowicz, M. Kaminska, W. Musial, R. Buechel, G. Sommer, G. Leibundgut, A. Rohner, J. Bremerich, B. Kaufmann, A. Kessel-Schaefer, M. Handke, A. Kiotsekoglou, S. Saha, R. Toole, S. Sharma, A. Gopal, S. Adhya, W. Tsang, C. Kenny, S. Kapetanakis, R. Lang, M. Monaghan, B. Smith, T. Coulter, A. Rendon, W.-S. Cheung, W. Gorissen, J. A. Ejlersen, O. May, F. J. Van Slochteren, T. Van Der Spoel, H. Hanssen, P. Doevendans, S. Chamuleau, C. De Korte, A. Tarr, S. Stoebe, T. Trache, J.-G. Kluge, A. Varga, A. Hagendorff, A. Nagy, A. Kovacs, A. Apor, B. Sax, D. Becker, B. Merkely, R. Lindquist, A. Miller, C. Reece, B. W. Eidem, W.-G. Choi, S. Kim, S. Oh, Y. Kim, R. Iacobelli, M. Chinali, M. D' Asaro, A. Toscano, A. Del Pasqua, C. Esposito, G. Seghetti, F. Parisi, G. Pongiglione, G. Rinelli, O. Omaygenc, R. Bakal, C. Dogan, K. Teber, S. Akpinar, G. Sahin, N. Ozdemir, A. Penhall, M. Joseph, F. Chong, C. De Pasquale, J. Selvanayagam, D. Leong, E. G. Nyktari, A. P. Patrianakos, C. Goudis, G. Solidakis, F. Parthenakis, P. Vardas, E. Nestaas, D. Fugelseth, A. Vitarelli, L. Capotosto, M. Bernardi, Y. Conde, F. Caranci, G. Placanica, O. Dettori, M. Vitarelli, S. De Chiara, V. De Cicco, M. Ferro', R. Calabro', S. Apostolakis, G. Chalikias, D. Tziakas, D. Stakos, A. Thomaidi, S. Konstantinides, G. Iorio, R. Rucos, G. Continanza, M. D Ascanio, L. Alessandroni, M. Saponara, M. Berry, J. Nahum, O. Zaghden, J. Monin, J. Couetil, O. Lairez, L. Macron, J. Dubois Rande, P. Gueret, P. Lim, M. Cameli, E. Giacomin, M. Lisi, S. Benincasa, F. Righini, D. Menci, M. Focardi, S. Mondillo, E. Philip, G. Gorincour, H. Bellsham-Revell, A. J. Bell, O. I. Miller, P. Beerbaum, R. Razavi, G. Greil, J. M. Simpson, S. Ann, T. Kim, J. Lee, J. Chin, P. Cabeza Lainez, V. Escolar Camas, L. Gheorghe, P. Fernandez Garcia, R. Vazquez Garcia, V. Caiulo, S. Caiulo, A. Fisicaro, F. Moramarco, G. Latini, A. Seale, J. Carvalho, H. Gardiner, M. Roughton, J. Simpson, A. Tometzki, O. Uzun, S. Webber, P. Daubeney, A. Dawood, G. Dwivedi, G. Mahadevan, D. Jiminez, R. Steeds, M. Frenneaux, C. H. Attenhofer Jost, B. Knechtle, A. Bernheim, M. Pfyffer, A. Linka, A. Faeh-Gunz, B. Seifert, G. De Pasquale, M. Zuber, A. Tomaszewski, A. Kutarski, and M. Tomaszewski

Subjects
Computer science, Plane (geometry), business.industry, Echo (computing), Left atrium, General Medicine, Biplane, medicine.anatomical_structure, Software, Left atrial, medicine, Radiology, Nuclear Medicine and imaging, Cardiology and Cardiovascular Medicine, business, Nuclear medicine
Published
2011
Full Text
View/download PDF

7. Poster session IV * Friday 10 December 2010, 14:00-18:00

Author

B. Mora, E. Base, W. Schmid, M. Andreas, U. Weber, M. Junreitmaier, F. Foerster, M. Hiesmayr, H. D. Tschernich, D. Guldbrand, O. Goetzsche, B. Eika, S. Fumagalli, S. Francini, D. Gabbai, S. Pedri, M. Casalone Rinaldi, Y. Makhanian, R. Sollami, F. Tarantini, N. Marchionni, P. M. Azcarate, S. Castano, M. Rodriguez-Manero, M. Arraiza, B. Levy, J. Barba, G. Rabago, G. Bastarrika, H. Rus, M. Radoi, C. Ciurea, D. Boda, T. Erdei, M. Denes, A. Mihalcz, A. Kardos, C. S. Foldesi, A. Temesvari, M. Lengyel, M. Cameli, M. Lisi, F. Righini, P. Ballo, M. Henein, S. Mondillo, S. Nistri, M. Galderisi, P. C. Ballo, L. Pagliani, I. Olivotto, A. Santoro, B. Papesso, P. Innelli, F. Cecchi, K. Hristova, T. Z. Katova, V. Kostova, Y. Simova, N. Nesheva, B. Ivanovic, M. T. Tadic, D. S. Simic, C. M. Rao, D. Aguglia, G. Casciola, C. Imbesi, A. Marvelli, M. Sgro, D. Benedetto, G. Tripepi, C. Zoccali, F. A. Benedetto, L. Mantziari, V. Kamperidis, E. Damvopoulou, I. Ventoulis, G. Giannakoulas, S. Paraskevaidis, V. Vassilikos, H. Karvounis, I. H. Styliadis, T. K. Sonder, B. B. Loegstrup, J. Lambrechtsen, L. M. Van Bortel, P. Segers, K. Egstrup, A. Tho, P. Moceri, D. Bertora, P. Gibelin, E. J. Cho, K. Y. Choi, B. J. Kim, D. B. Kim, S. W. Jang, C. S. Park, H. O. Jung, H. K. Jeon, H. J. Youn, J. H. Kim, E. Donal, N. Coquerel, S. Bodi, C. Thebault, G. Kervio, F. Carre, M. J. Daly, S. L. Fairley, R. Doherty, K. Ashfield, R. Kirkpatrick, B. Smith, J. Buchanan, L. Hill, L. J. Dixon, M. Rosca, K. O' Connor, J. Magne, G. Romano, A. Calin, B. A. Popescu, C. C. Beladan, L. Pierard, C. Ginghina, P. Lancellotti, T. Bochenek, K. Wita, Z. Tabor, M. Grabka, M. Elzbieciak, M. Trusz-Gluza, O. Moreau, C. Leclercq, A. Sahlen, K. Shahgaldi, A. Aminoff, P. Aagaard, A. Manouras, R. Winter, E. Ehrenborg, F. Braunschweig, G. Bedetti, L. Gargani, C. Pizzi, R. Sicari, E. Picano, J. Zhang, H. B. Zhang, Y. Y. Duan, L. L. Chen, J. Li, L. W. Liu, T. Zhu, H. L. Li, H. L. Su, X. D. Zhou, M. Ruiz Ortiz, D. Mesa Rubio, M. Delgado Ortega, E. Romo Penas, F. Toledano Degado, C. Leon Del Pino, J. Lopez Aguilera, E. Villanueva Fernandez, L. Cejudo Diaz Del Campo, J. Suarez De Lezo, E. Abergel, M. Simon, P. Dehant, E. Bogino, M. Jimenez, J. C. Verdier, C. Chauvel, A. E. Albertsen, J. C. Nielsen, P. T. Mortensen, H. Egeblad, G. M. Nasr, S. Tawfik, A. Omar, M. Olofsson, K. Boman, N. Rezzoug, B. Vaes, J. Degryse, J.-L. Vanoverschelde, A. A. Pasquet, D. Poggio, M. Bonadies, V. Pacher, S. Mazzetti, M. Grillo, E. D'elia, T. Khouri, G. Specchia, C. Mornos, D. Rusinaru, D. Cozma, A. Ionac, L. Petrescu, R. Rotzak, Y. Rosenman, R. D. Patterson, S. Ratnatheepan, R. G. Bogle, B. Goebel, O. Gjesdal, D. Kottke, S. Otto, C. Jung, T. Edvardsen, H. R. Figulla, T. C. Poerner, T. Otsuka, M. Suzuki, H. Yoshikawa, G. Hashimoto, N. Itou, T. Ono, M. Yamamoto, T. Osaki, T. Tsuchida, K. Sugi, T. Wolber, L. Haegeli, D. Huerlimann, C. Brunckhorst, F. Duru, Z. M. Wu, X. H. Shu, L. L. Dong, B. Fan, J. B. Ge, M. Greutmann, D. Tobler, P. Biaggi, M. Mah, A. Crean, E. N. Oechslin, C. K. Silversides, S. Giusca, R. Jurcut, I. Ghiorghiu, I. M. Coman, M. Amzulescu, R. Ionescu, M. Delcroix, J. U. Voigt, R. Piatkowski, J. Kochanowski, P. Scislo, M. Grabowski, M. Marchel, M. Roik, D. Kosior, G. Opolski, A. M. Maceira Gonzalez, J. Cosin-Sales, E. Dalli, B. Igual, J. V. Monmeneu, P. Lopez-Lereu, J. Estornell, J. Ruvira, J. Sotillo, A. Stevanovic, A. Toncev, S. Dimkovic, M. Dekleva, N. Paunovic, D. Toncev, N. Sekularac, O. Yildirimturk, F. F. Helvacioglu, Y. Tayyareci, S. Yurdakul, I. C. C. Demiroglu, S. Aytekin, M. Pinedo Gago, I. Amat Santos, A. Revilla Orodea, J. Lopez Diaz, R. Arnold, L. De La Fuente Galan, A. Recio Platero, I. Gomez Salvador, A. Puerto Sanz, J. A. San Roman Calvar, R. Yotti, J. Bermejo, T. Mombiela, Y. Benito, P. L. Sanchez, J. Solis, R. Prieto, F. Fernandez-Aviles, R. Zilberszac, H. Gabriel, S. Graf, G. Mundigler, G. Maurer, R. Rosenhek, C. Zito, J. Salvia, C. Longordo, D. Donato, E. Alati, M. Miceli, A. Pardeo, S. Arcidiaco, G. Oreto, S. Carerj, S. Hadjimiltiades, G. Sianos, K. Anastasiadis, V. Grosomanidis, G. Efthimiadis, G. Parcharidis, M. Yousry, A. Rickenlund, J. Petrini, T. Gustafsson, J. Liska, A. Hamsten, P. Eriksson, A. Franco-Cereceda, M. J. Eriksson, K. Caidahl, K. Mizia-Stec, P. Pysz, M. Jasinski, A. Drzewiecka-Gerber, M. Krejca, A. Bochenek, S. Wos, Z. Gasior, M. Tendera, K. Niki, M. Sugawara, I. Takamisawa, H. Watanabe, T. Sumiyoshi, S. Hosoda, T. Ida, S. Takanashi, N. T. Olsen, P. Sogaard, C. Jons, R. Mogelvang, H. B. W. Larsson, J. P. Goetze, O. W. Nielsen, T. Fritz-Hansen, N. Sayar, A. L. Orhan, H. B. Erer, M. Eren, H. Atmaca, H. Y. Yilmaz, N. Cakmak, S. Altay, S. Terzi, K. Yesilcimen, R. Garcia Orta, E. Moreno, M. Lopez, I. Uribe, M. Vidal, M. F. Ruiz-Lopez, M. Gonzalez-Molina, J. M. Oyonarte, S. Lopez, J. Azpitarte, C. Szymanski, R. A. Levine, H. Zheng, M. D. Handschumacher, A. Tawakol, J. Hung, F. Le Ven, Y. Etienne, Y. Jobic, I. Frachon, P. Castellant, M. Fatemi, J. J. Blanc, C. Tribouilloy, F. Grigioni, J.-F. Avierinos, A. Barbieri, O. Buiciuc, M. Enriquez-Sarano, K. Said, A. K. Farag, M. El-Ramly, H. Rizk, A. Iorio, B. Pinamonti, M. Bobbo, M. Merlo, L. Massa, G. Faganello, A. Di Lenarda, G. Sinagra, R. Margato, H. Ribeiro, C. Ferreira, A. Matias, P. Fontes, J. I. Moreira, A. Milan, E. Puglisi, C. Magnino, A. Fabbri, D. Leone, A. Vairo, V. Crudo, A. Iannaccone, V. Milazzo, F. Veglio, N. Maroz-Vadalazhskaya, I. Ostrovskiy, E. Imbalzano, A. Saitta, M. Cusma-Piccione, G. Di Bella, R. Nava, M. Ferro, G. Falanga, A. Frigy, J. Buzogany, C. S. Szabados, L. Dan, E. Carasca, I. Ikonomidis, J. Lekakis, S. Tzortzis, D. T. Kremastinos, C. Papadopoulos, I. Paraskevaidis, H. Triantafyllidi, P. Trivilou, K. Venetsanou, M. Anastasiou-Nana, K. Wierzbowska-Drabik, M. Kurpesa, E. Trzos, T. Rechcinski, M. Mozdzan, J. D. Kasprzak, W. Kosmala, T. Kotwica, M. Przewlocka-Kosmala, A. Mysiak, D. Skultetyova, S. Filipova, P. Chnupa, G. Pechlivanidis, H. Dimitroula, W.-C. Tsai, Y.-W. Liu, C.-C. Lin, Y.-Y. Huang, L.-M. Tsai, S. M. Park, Y. H. Kim, S. M. Shin, W. J. Shim, A. Gonzalez Mansilla, J. Torres Macho, V. Sanchez Sanchez, P. Diez, J. Delgado, S. Borruel, C. Saenz De La Calzada, S. Pyxaras, M. Valentincic, G. Barbati, F. Lo Giudice, A. Perkan, S. Magnani, T. Palecek, D. Ambroz, P. Jansa, J. Lindner, M. Vitovec, P. Polacek, K. Jiratova, A. Linhart, M. Baskurt, G. M. Dogan, O. Abaci, A. Kaya, S. Kucukoglu, A. Duszanska, T. Kukulski, I. Skoczylas, A. Majsnerowska, A. Nowowiejska-Wiewiora, W. Streb, M. Szulik, L. Polonski, Z. Kalarus, P. O. Yerly, M. Prella, A. Joly, L. Nicod, J. D. Aubert, N. Aebischer, H. Dores, S. Leal, I. Rosario, M. J. Correia, J. Monge, A. M. Grilo, I. Arroja, C. Fonseca, A. Aleixo, A. Silva, E. Perez-David, M. Sanchez-Alegre, I. Gomez Anta, J. De La Torre, J. Alarcon, J. A. Garcia Robles, J. Lafuente, C. J. Garcia Alonso, N. Vallejo Camazon, A. Gonzalez Guardia, R. Nunez, C. Bosch Carabante, L. Mateu, F. Gual Capllonch, E. Ferrer Sistach, J. Lopez Ayerbe, A. Bayes Genis, A. Tomaszewski, A. Kutarski, M. Tomaszewski, D. Bramos, A. Kalantaridou, D. Takos, E. Skaltsiotis, C. Trika, N. Tsirikos, C. Pamboukas, G. Kottis, S. Toumanidis, C. Aggeli, I. Felekos, G. Roussakis, C. Kazazaki, K. Lampropoulos, S. Lagoudakou, C. Stergiou, C. Pitsavos, C. Stefanadis, C. Kihara, K. Murata, Y. Wada, T. Tanaka, K. Uchida, S. Okuda, T. Susa, M. Matsuzaki, A. Abrahamsson, P. Gudmundsson, L. Brodin, F. Knebel, S. Schattke, W. Sanad, I. Schimke, S. Schroeckh, L. Brechtel, J. Lock, R. Makauskiene, G. Baumann, A. C. Borges, H. E. Moelmen-Hansen, U. Wisloff, I. L. Aamot, A. Stoylen, C. B. Ingul, M.-E. Estensen, J. O. Beitnes, G. Grindheim, T. Henriksen, L. Aaberge, O. A. Smiseth, L. Gullestad, S. Aakhus, G. Agoston, A. Moggi Pignone, E. Capati, L. Badano, A. Moreo, S. Bombardieri, A. Varga, M. Carrideo, S. Faricelli, A. Corazzini, R. Ippedico, B. Ruggieri, A. Di Blasio, E. D'angelo, A. Di Baldassarre, P. Ripari, S. Gallina, A. Kentrschynskyj, B. Hylander, S. Jacobson, A. Pagels, S. I. Dumitrescu, I. Tintoiu, V. Greere, G. Cristian, L. Chiriac, F. Pinte, I. Droc, G. Neagoe, S. Stanciu, V. A. Voicu, A. Kuch-Wocial, P. Pruszczyk, C. A. Szmigielski, M. Szulc, G. Styczynski, M. Sinski, A. Kaczynska, A. Ryabikov, S. Malyutina, J. Halcox, M. Bobak, Y. U. Nikitin, M. Marmot, D. Barbosa, G. Kiss, F. Orderud, B. Amundsen, R. Jasaityte, D. Loeckx, P. Claus, H. Torp, J. D'hooge, J. T. Kuhl, J. Lonborg, A. Fuchs, M. Andersen, N. Vejlstrup, T. Engstrom, J. E. Moller, K. F. Kofoed, L. A. Smith, A. Bhan, M. Paul, M. J. Monaghan, B. Zaborska, S. Stec, M. Sikora-Frac, T. Krynski, P. Kulakowski, K. Pushparajah, D. Dashwood, A. Barlow, K. Nugent, O. Miller, J. Simpson, N. Valeur, M. K. Ersboll, J. Kjaergaard, R. Greibe, N. Risum, C. Hassager, L. Kober, D. Popovic, I. Nedeljkovic, M. Petrovic, B. Vujisic-Tesic, A. Arandjelovic, S. Stojiljkovic, B. Jakovljevic, S. Damjanovic, M. Ostojic, I. A. Agrios, D. B. Bramos, H. S. Skaltsiotis, D. T. Takos, A. Kaladaridis, N. V. Vasiladiotis, G. K. Kottis, A. A. Antoniou, C. P. Pamboucas, S. T. T. Toumanidis, G. Locorotondo, I. Porto, L. Paraggio, E. Fedele, S. Barchetta, A. R. De Caterina, A. G. Rebuzzi, F. Crea, L. Galiuto, P. Lipiec, E. Szymczyk, B. Michalski, B. Wozniakowski, L. Stefanczyk, A. Rotkiewicz, A. Shim, J. Vainer, J. Habets, A. Lousberg, C. Pont De, J. Waltenberger, H. Farouk, H. Heshmat, A. Adel, K. El Chilali, Y. Baghdady, K. Sorour, U. Gustafsson, M. Larsson, A. Bjallmark, P. Lindqvist, R. A'roch, M. Haney, A. Waldenstrom, Z. Mladenovic, D. Tavciovski, Z. Mijailovic, A. Djordjevic - Dikic, S. Obradovic, R. Matunovic, Z. Jovic, P. Djuric, S. Aase, H. Dalen, T. Sarkola, A. N. Redington, F. Keeley, T. Bradley, E. Jaeggi, and H. Sahlen

Subjects
medicine.medical_specialty, medicine.anatomical_structure, Myocardial ischemia, business.industry, Ventricle, Internal medicine, Cardiology, Medicine, Radiology, Nuclear Medicine and imaging, General Medicine, Cardiology and Cardiovascular Medicine, business, Rotation
Published
2010
Full Text
View/download PDF

8. Poster session I * Thursday 9 December 2010, 08:30-12:30

Author

V. A. Kuznetsov, A. O. Kozhurina, A. V. Plusnin, M. Szulik, B. Sredniawa, W. Streb, R. Lenarczyk, J. Stabryla-Deska, A. Sedkowska, O. Kowalski, Z. Kalarus, T. Kukulski, T. M. Katova, A. Nesheva, I. Simova, K. Hristova, V. Kostova, L. Boiadjiev, N. Dimitrov, M. P. Papamichalis Michalis, S. G. Sitafidis George, B. D. Dimopoulos Basilios, G. K. Kelepesis Glafkos, D. E. Economou Dimitrios, J. S. Skoularigis John, F. T. Triposkiadis Filippos, C. H. Attenhofer Jost, M. Pfyffer, B. Naegeli, P. Levis, A. Faeh-Gunz, H. P. Brunner-Larocca, M. S. Velasco Del Castillo, A. Cacicedo, J. J. Onaindia, J. Gonzalez Ruiz, A. Subinas, J. A. Alarcon, O. Quintana, I. Rodriguez, E. Laraudogoitia, Y.-Y. Lam, M. Y. Henein, A. Mazzone, A. Vianello, S. Perlini, A. I. Corciu, S. Cappelli, A. Cerillo, D. Chiappino, S. Berti, M. Glauber, S. Herrmann, M. Niemann, S. Stoerk, J. Strotmann, W. Voelker, G. Ertl, F. Weidemann, Z. Y. Yong, K. Boerlage - Van Dijk, K. T. Koch, M. M. Vis, B. J. Bouma, J. P. S. Henriques, R. Cocchieri, B. A. J. M. De Mol, J. J. Piek, J. Baan, N. G. J. Keenan, C. Cueff, C. Cimadevilla, E. Brochet, L. Lepage, D. Detaint, B. Iung, A. Vahanian, D. Messika-Zeitoun, T. Otsuka, M. Suzuki, H. Yoshikawa, G. Hashimoto, T. Osaki, T. Tsuchida, M. Matsuyama, H. Yamashita, S. Ozaki, K. Sugi, C. J. Garcia Alonso, N. Vallejo Camazon, E. Ferrer Sistach, M. L. Camara, J. Lopez Ayerbe, C. Bosch Carabante, M. Espriu Simon, F. Gual Capllonch, A. Bayes Genis, G. Deswarte, C. Vanesson, A. S. Polge, D. Huchette, T. Modine, P. Marboeuf, N. Lamblin, C. Bauters, G. Deklunder, T. Le Tourneau, A. Agricola, M. Gullace, S. Stella, R. D'amato, M. Slavich, M. Oppizzi, M. Ancona, A. Margonato, F. Le Ven, Y. Etienne, Y. Jobic, I. Frachon, P. Castellant, M. Fatemi, J. J. Blanc, M. Muratori, P. Montorsi, F. Maffessanti, P. Gripari, G. Teruzzi, S. Ghulam Ali, L. Fusini, F. Celeste, M. Pepi, B. Goebel, K. Haugaa, K. Meyer, S. Otto, A. Lauten, C. Jung, T. Edvardsen, H. R. Figulla, T. C. Poerner, H. Aksoy, S. Okutucu, B. Evranos, K. Aytemir, E. B. Kaya, G. Kabakci, L. Tokgozoglu, H. Ozkutlu, A. Oto, N. Valeur, H. H. Pedersen, R. Videbaek, C. Hassager, J. H. Svendsen, L. Kober, M. K. Tigen, T. Karaahmet, E. Gurel, S. Pala, C. Dundar, Y. Basaran, C. I. Caldararu, E. Ene, M. Dorobantu, R. G. Vatasescu, M. Cikes, B. Bijnens, H. Gasparovic, F. Siric, V. Velagic, D. Lovric, J. Samardzic, B. Ferek-Petric, D. Milicic, B. Biocina, J. Kjaergaard, S. Ghio, M. St John Sutton, O. Moreau, G. Kervio, C. Thebault, C. Leclercq, E. Donal, C. Mornos, D. Rusinaru, L. Petrescu, D. Cozma, A. Ionac, S. Pescariu, S. I. Dragulescu, M. Z. Petrovic, B. Vujisic-Tesic, G. Milasinovic, M. T. Petrovic, I. Nedeljkovic, D. Zamaklar-Trifunovic, Z. Calovic, V. Jelic, M. Boricic, I. Petrovic, P. Kuchynka, T. Palecek, S. Simek, E. Nemecek, J. Horak, D. Hulinska, J. Schramlova, I. Vitkova, V. Aster, A. Linhart, L. Paluszkiewicz, D. Guersoy, S. Ozegowski, S. Spiliopoulos, R. Koerfer, G. Tenderich, M. Gaggl, G. Heinze, G. Sunder-Plassmann, S. Graf, M. Zehetmayer, T. Voigtlaender, C. Mannhalter, E. Paschke, G. Fauler, G. Mundigler, M. Tesic, D. Trifunovic, A. Djordjevic-Dikic, O. Petrovic, M. Petrovic, B. Beleslin, M. Ostojic, G. Draganic, C. E. Correia, B. Rodrigues, L. F. Santos, D. Moreira, P. Gama, L. Nunes, C. Nascimento, O. Dionisio, O. Santos, C. Prinz, O. Oldenburg, T. Bitter, C. Piper, D. Horstkotte, L. Faber, A. Nemes, H. Gavaller, M. Csanady, T. Forster, M. Calcagnino, C. O'mahony, K. Tsovolas, P. D. Lambiase, P. Elliott, A. S. Olezac, A. Bensaid, J. Nahum, E. Teiger, J. L. Dubois-Rande, P. Gueret, P. Lim, C. Langer, M. Kansal, P. Surapaneni, P. P. Sengupta, S. J. Lester, S. R. Ommen, S. W. Ressler, R. T. Hurst, V. Monivas Palomero, S. Mingo Santos, C. Mitroi, I. Garcia Lunar, P. Garcia Pavia, J. Gonzalez Mirelis, L. Ruiz Bautista, V. Castro Urda, J. Toquero Ramos, I. Fernandez Lozano, A. Sommer, S. H. Poulsen, J. Mogensen, L. Thuesen, H. Egeblad, R. Montisci, M. Ruscazio, A. Vacca, P. Garau, F. Tuveri, C. Soro, A. Matthieu, L. Meloni, W. Kosmala, M. Przewlocka-Kosmala, A. Wojnalowicz, A. Mysiak, T. H. Marwick, R. Yotti, C. Ripoll, J. Bermejo, Y. Benito, T. Mombiela, D. Rincon, A. Barrio, R. Banares, F. Fernandez-Aviles, A. Tomaszewski, A. Kutarski, M. Tomaszewski, R. Ticulescu, O. Vriz, L. Sparacino, B. A. Popescu, C. Ginghina, G. L. Nicolosi, S. Carerj, F. Antonini-Canterin, E. Agricola, L. Bertoglio, G. Melissano, R. Chiesa, S. Garcia Blas, D. Iglesias Del Valle, T. Lopez Fernandez, J. J. Gomez De Diego, M. C. Monedero Martin, F. J. Dominguez, M. Moreno Yanguela, J. L. Lopez Sendon, S. Adhya, F. D. Murgatroyd, M. Monaghan, L. Spinarova, J. Meluzin, P. Hude, J. Krejci, H. Podrouzkova, M. Pesl, R. Panovsky, L. Dusek, M. Orban, J. Korinek, C. Hammerstingl, M. Schwiekendik, G. Nickenig, D. Momcilovic, L. Lickfett, C. C. Beladan, A. Calin, M. Rosca, D. Muraru, F. Voinea, E. Popa, F. Matei, F. Curea, G. Di Salvo, G. Pacileo, S. Gala, B. Castaldi, A. F. D'aiello, A. Mormile, L. Baldini, M. G. Russo, R. Calabro, P. S. Halvorsen, G. Dahle, J. F. Bugge, B. Bendz, L. Aaberge, K. A. Rein, A. Fiane, J. Bergsland, E. Fosse, S. Aakhus, L. P. Koopman, N. Chahal, C. Slorach, W. Hui, T. Sarkola, C. Manlhiot, T. J. Bradley, E. T. Jaeggi, B. W. Mccrindle, L. Mertens, F. A. D'aiello, A. Mormilw, A. Rea, K. O'Connor, G. Romano, J. Magne, L. Pierard, P. Lancellotti, T. Arita, K. Ando, A. Isotani, Y. Soga, M. Iwabuchi, M. Nobuyoshi, M. Wiesen, D. Skowasch, F. Breunig, M. Beer, K. Hu, C. Wanner, M. A. Morel, Y. F. Bernard, V. Descotes-Genon, N. Meneveau, F. Schiele, A. Vitarelli, M. Bernardi, A. Scarno, F. Caranci, V. Padella, O. Dettori, L. Capotosto, M. Vitarelli, V. De Cicco, P. Bruno, G. Bajraktari, P. Lindqvist, U. Gustafsson, A. Holmgren, M. Hassan, K. Said, E. Baligh, H. Farouk, D. Osama, M. F. Elmahdy, A. Elfaramawy, K. Sorour, M. Luckie, A. Zaidi, A. Fitzpatrick, R. S. Khattar, J. Schwartz, O. Huttin, B. Popovic, P. Y. Zinzius, C. Christophe, O. Marcon, L. Groben, Y. Juilliere, F. Chabot, C. Selton-Suty, B. Krastev, E. T. K. Kinova, N. I. Z. Zlatareva, A. R. G. Goudev, A. J. Teske, B. W. De Boeck, F. A. Mohames Hoesein, V. Van Driel, P. Loh, M. J. Cramer, P. A. Doevendans, F. Dillenburg, K. M. Abd El Salam, E. M. M. Ho, M. Hall, L. Hemeryck, K. Bennett, K. Scott, G. King, R. T. Murphy, A. Mahmud, A. S. Brown, H. Dalen, A. Thorstensen, P. R. Romundstad, S. A. Aase, A. Stoylen, L. Vatten, T. Bochenek, K. Wita, Z. Tabor, A. Doruchowska, M. Lelek, M. Trusz-Gluza, E. Hamodraka, I. Paraskevaidis, A. Karamanou, C. Michalakeas, H. Vrettou, E. Kapsali, D. Tsiapras, I. Lekakis, M. Anastasiou-Nana, D. Kremastinos, L. Sirugo, V. E. Bottari, S. Licciardi, A. Blundo, A. Atanasio, I. P. Monte, C. S. Park, J. H. Kim, J. S. Cho, M. J. Kim, E. J. Cho, S. H. Ihm, H. O. Jung, H. K. Jeon, H. J. Youn, K. S. Kim, A. Fontana, L. Taravella, A. Zambon, G. Trocino, C. Giannattasio, A. Kalinin, M. Alekhin, G. Bahs, A. Lejnieks, A. Kalvelis, A. Kalnins, P. Shipachovs, E. Zakharova, G. Blumentale, M. Trukshina, T. Biering-Sorensen, R. Mogelvang, S. Haahr-Pedersen, P. Schnohr, P. Sogaard, J. Skov Jensen, L. Gargani, G. Agoston, E. Capati, L. Badano, A. Moreo, M. F. Costantino, M. L. Caputo, S. Mondillo, R. Sicari, E. Picano, E. G. Malev, E. V. Timofeev, S. V. Reeva, E. V. Zemtsovsky, R. Piazza, R. Enache, A. Roman-Pognuz, E. Leiballi, R. Pecoraro, H. Sadeghian, M. Lotfi_Tokaldany, M. Rezvanfard, A. Kasemisaeid, S. Majidi, M. Montazeri, M. Saber-Ayad, Y. S. Nassar, A. Farhan, A. Moussa, A. El-Sherif, R. M. Cooper, J. D. Somauroo, R. E. Shave, K. L. Williams, J. Forster, C. George, T. Bett, D. C. Gaze, K. P. George, N. Mansencal, A. Dupland, V. Caille, S. Perrot, K. Bouferrache, A. Vieillard-Baron, R. Jouffroy, S. G. Cioroiu, O. S. Alexe, E. Bobescu, H. Rus, V. Schiano Lomoriello, R. Esposito, A. Santoro, R. Raia, F. Farina, R. Ippolito, M. Galderisi, E. H. Aburawi, P. Malcus, A. Thuring, A. Maxedius, E. Pesonen, S. V. Nair, E. Joyce, L. Lee, J. Shrimpton, E. Newman, P. R. James, C. Jurcut, S. Caraiola, R. O. Jurcut, S. Giusca, D. Nitescu, M. S. Amzulescu, I. Copaci, C. Tanasescu, J. Silva Marques, D. Silva, F. Ferreira, P. C. Ferreira, A. G. Almeida, J. Martim Martins, M. G. Lopes, L. Bergenzaun, M. Chew, A. Ersson, P. Gudmundsson, H. Ohlin, A. Borowiec, R. Dabrowski, J. Wozniak, S. Jasek, T. Chwyczko, I. Kowalik, E. Musiej-Nowakowska, H. Szwed, Y. L. Wen, J. Tian, L. Yan, H. Cheng, H. Yang, B. Luo, J. Wang, H. Kozman, D. Villarreal, K. Liu, A. Karavidas, D. Tsiachris, G. Lazaros, V. Matzaraki, G. Xylomenos, G. Levendopoulos, S. Arapi, A. Perpinia, E. Matsakas, V. Pyrgakis, Y. W. Liu, C. T. Su, W. C. Tsai, J. W. Huang, K. Y. Hung, J. H. Chen, M. Larsson, F. Kremer, T. Kouznetsova, A. Bjallmark, B. Lind, L.-A. Brodin, J. D'hooge, M. Caputo, G. Antonelli, M. Lisi, E. Giacomin, S. Moustafa, M. Alharthi, Y. Deng, K. Chandrasekaran, F. Mookadam, S. Y. Hayashi, M. M. Nascimento, B. Lindholm, A. Seeberger, J. Nowak, M. C. Riella, L. A. Brodin, A. Theodosis, E. Fousteris, G. Tsiaousis, A. Krommydas, P. Margetis, Z. Katidis, D. Beldekos, S. Argirakis, A. Melidonis, S. Foussas, O. Khaleva, O. Onyshchenko, E. Lukaschuk, N. Sherwi, N. Nikitin, J. G. F. Cleland, N. Risum, C. Jons, N. T. Olsen, M. B. Kronborg, M. T. Jensen, T. Fritz-Hansen, N. E. Bruun, M. V. Hojgaard, J. Petrini, M. Yousry, A. Rickenlund, J. Liska, A. Franco-Cereceda, A. Hamsten, P. Eriksson, K. Caidahl, M. J. Eriksson, N. Elmstedt, K. Ferm-Widlund, M. Westgren, E. Szymczyk, J. D. Kasprzak, B. Wozniakowski, A. Rotkiewicz, K. Szymczyk, L. Stefanczyk, B. Michalski, P. Lipiec, L. Ring, T. Eller, P. Deegan, R. Rusk, J. A. Urbano Moral, J. A. Arias, J. T. Kuvin, A. R. Patel, N. G. Pandian, H. Bellsham-Revell, A. J. Bell, O. Miller, G. F. Greil, J. Simpson, R. Ancona, S. Comenale Pinto, P. Caso, S. Severino, L. Nunziata, T. Roselli, C. Dussault, S. Lafitte, G. Habib, P. Reant, G. Derumeaux, H. Thibault, A. Kaladaridis, I. A. Agrios, C. P. Pamboucas, S. M. Mesogitis, N. V. Vasiladiotis, D. B. Bramos, S. T. T. Toumanidis, A. R. Martiniello, G. Santangelo, G. Pedrizzetti, G. Tonti, C. Cioppa, M. Cavallaro, V. Calvi, and R. Chianese

Subjects
Speckle pattern, Longitudinal strain, business.industry, Carotid arteries, Medicine, Radiology, Nuclear Medicine and imaging, General Medicine, Cardiology and Cardiovascular Medicine, business, Tracking (particle physics), Biomedical engineering
Abstract

Radial and longitudinal strain assessment in the carotid artery wall using speckle tracking

Published
2010
Full Text
View/download PDF

9. Poster session II * Thursday 9 December 2010, 14:00-18:00

Author

P. A. Pabari, A. Kyriacou, M. Moraldo, B. Unsworth, R. Baruah, N. Sutaria, A. Hughes, J. Mayet, D. P. Francis, T. Uejima, K. Loboz, F. Antonini-Canterin, C. Polombo, S. Carerj, D. Vinereanu, A. Evangelista, G. Leftheriotis, A. G. Fraser, A. Kiotsekoglou, M. Govindan, S. C. Govind, S. K. Saha, A. J. Camm, P. M. Azcarate, S. Castano, M. Rodriguez-Manero, M. Arraiza, B. Levy, J. Barba, G. Rabago, G. Bastarrika, A. Nemes, R. Takacs, T. Varkonyi, H. Gavaller, I. Baczko, T. Forster, T. Wittmann, J. G. Papp, C. Lengyel, A. Varro, L. R. Tumasyan, K. G. Adamyan, O. Savu, T. Mieghem, P. Dekoninck, L. Gucciardo, R. Jurcut, S. Giusca, B. A. Popescu, C. Ginghina, J. Deprest, J. U. Voigt, M. Versiero, M. Galderisi, R. Esposito, A. Rapacciuolo, G. Esposito, R. Raia, T. Morgillo, F. Piscione, G. De Simone, M. A. Oraby, F. A. Maklady, E. M. Mohamed, A. Z. Eraki, D. Zaliaduonyte-Peksiene, E. Tamuleviciute, J. Janenaite, J. Marcinkeviciene, V. Mizariene, S. Bucyte, J. Vaskelyte, D. Trifunovic, I. Nedeljkovic, D. Popovic, M. Ostojic, B. Vujisic-Tesic, M. Petrovic, S. Stankovic, D. Sobic-Saranovic, M. Banovic, A. Dikic-Djordjevic, K. Savino, A. Lilli, E. Grikstaite, V. Giglio, E. Bordoni, G. Maragoni, C. Cavallini, G. Ambrosio, B. Jakovljevic, B. Beleslin, M. Nedeljkovic, O. Petrovic, S. Moral, J. Rodriguez-Palomares, M. Descalzo, G. Marti, V. Pineda, P. Mahia, L. Gutierrez, T. Gonzalez-Alujas, D. Garcia-Dorado, F. Schnell, E. Donal, C. Thebault, A. Bernard, H. Corbineau, H. Le Breton, J. Kochanowski, P. Scislo, R. Piatkowski, M. Roik, M. Marchel, D. Kosior, G. Opolski, A. M. Lesniak-Sobelga, E. Wicher-Muniak, M. Kostkiewicz, M. Olszowska, E. Suchon, P. Klimeczek, P. Banys, M. Pasowicz, W. Tracz, P. Podolec, A. Laynez, D. E. Hoefsten, B. B. Loegstrup, B. Norager, J. E. Moller, A. Flyvbjerg, K. Egstrup, W. Streb, M. Szulik, J. Nowak, E. Markowicz-Pawlus, A. Duszanska, A. Sedkowska, Z. Kalarus, T. Kukulski, L. Spinelli, C. Morisco, E. Assante Di Panzillo, F. Buono, S. Crispo, B. Trimarco, A. A. Hawary, G. M. Nasr, M. M. Fawzy, L. Faber, W. Scholtz, J. Boergermann, M. Wiemer, G. Kleikamp, N. Bogunovic, Z. Dimitriadis, J. Gummert, D. Hering, D. Horstkotte, F. Luca', S. Gelsomino, R. Lorusso, S. Caciolli, R. Carella, G. Bille', G. De Cicco, V. Pazzagli, G. F. Gensini, A. Borowiec, R. Dabrowski, J. Janas, A. Kraska, B. Firek, I. Kowalik, H. Szwed, K. A. Marcus, C. L. De Korte, T. Feuth, J. M. Thijssen, L. Kapusta, J. Dahl, L. Videbaek, M. K. Poulsen, P. A. Pellikka, K. Veien, L. I. Andersen, T. Haghfelt, M. Haberka, K. Mizia - Stec, T. Adamczyk, M. Mizia, A. Chmiel, P. Pysz, M. Sosnowski, Z. Gasior, M. Trusz - Gluza, M. Tendera, T. Niklewski, K. Wilczek, P. Chodor, T. Podolecki, A. Frycz-Kurek, M. Zembala, S. Yurdakul, O. Yildirimturk, Y. Tayyareci, K. Memic, I. C. C. Demiroglu, S. Aytekin, C. J. Garcia Alonso, E. Ferrer Sistach, L. Delgado, J. Lopez Ayerbe, N. Vallejo Camazon, F. Gual Capllonch, M. Espriu Simon, X. Ruyra, A. Caballero Parrilla, A. Bayes Genis, L. Lecuyer, A. Berrebi, E. Florens, M. Noghin, C. Huerre, P. Achouh, R. Zegdi, J. N. Fabiani, B. De Chiara, A. Moreo, F. Musca, F. De Marco, E. Lobiati, O. Belli, F. Mauri, S. Klugmann, A. Caballero, N. Vallejo, A. Gonzalez Guardia, R. Nunez Aragon, C. Bosch, E. Ferrer, M. L. Pedro Botet, F. Gual, M. Cusma-Piccione, C. Zito, G. Oreto, R. Giuffre, M. C. Todaro, C. M. Barbaro, S. Lanteri, C. Longordo, J. Salvia, A. Bensaid, R. Gallet, E. Fougeres, P. Lim, J. Nahum, J. F. Deux, P. Gueret, E. Teiger, J. L. Dubois-Rande, J. L. Monin, F. Behramoglu, Z. Colakoglu, V. Aytekin, C. Demiroglu, L. Gargani, E. Poggianti, R. Bucalo, M. Rizzo, F. Agrusta, P. Landi, R. Sicari, E. Picano, A. Sutandar, B. B. Siswanto, I. Irmalita, G. Harimurti, S. Y. Hayashi, M. M. Nascimento, B. Lindholm, B. Lind, A. Seeberger, M. A. Pachaly, M. C. Riella, A. Bjallmark, L. A. Brodin, L. Poanta, M. Porojan, D. L. Dumitrascu, I. Ikonomidis, S. Tzortzis, J. Lekakis, D. T. Kremastinos, I. Paraskevaidis, I. Andreadou, M. Nikolaou, P. Katsibri, M. Anastasiou-Nana, A. M. Maceira Gonzalez, C. Ripoll, J. Cosin-Sales, B. Igual, J. Salazar, V. Belloch, J. Cosin-Aguilar, D. J. Pennell, M. Masaki, J. N. Pulido, T. Yuasa, S. Gillespie, B. Afessa, D. R. Brown, S. V. Mankad, J. K. Oh, A. L. Gurghean, A. M. Mihailescu, I. Tudor, C. Homentcovschi, M. Muraru, I. V. Bruckner, C. E. Correia, B. Rodrigues, D. Moreira, L. F. Santos, P. Gama, O. Dionisio, C. Cabral, O. Santos, T. Bombardini, S. Gherardi, G. Arpesella, S. Valente, I. Calamai, E. Pasanisi, S. Sansoni, P. Szymanski, P. Dobrowolski, M. Lipczynska, A. Klisiewicz, P. Hoffman, D. Stepowski, B. Kurtz, G. Grezis-Soulie, A. Savoure, F. Anselme, F. Bauer, J. Castillo, N. Herszkowicz, C. Ferreira, A. Goscinska, K. Mizia-Stec, W. Poborski, O. Azevedo, I. Quelhas, J. Guardado, M. Fernandes, C. S. Miranda, P. Gaspar, A. Lourenco, R. Medeiros, J. Almeida, S. L Bennani, V. Algalarrondo, S. Dinanian, J. Guiader, C. Juin, D. Adams, M. S. Slama, J. J. Onaindia, O. Quintana, S. Velasco, E. Astigarraga, A. Cacicedo, J. Gonzalez, I. Rodriguez, M. Sadaba, M. Eneriz, E. Laraudogoitia Zaldumbide, I. Nunez-Gil, M. Luaces, J. Zamorano, J. C. Garcia Rubira, D. Vivas, B. Ibanez, P. Marcos Alberca, C. Fernandez Golfin, J. Alonso, C. Macaya, J. Silva Marques, A. G. Almeida, V. Carvalho, C. Jorge, D. Silva, M. Gato Varela, S. Martins, D. Brito, M. G. Lopes, E. Tripodi, B. Miserrafiti, V. Montemurro, R. Scali, P. Tripodi, A. Winkler, A. Madej, I. Hausmanowa-Petrusewicz, M. Fijalkowski, A. Koprowski, M. Jaguszewski, R. Galaska, M. Taszner, A. Rynkiewicz, R. Citro, F. Rigo, G. Provenza, Q. Ciampi, M. M. Patella, A. D'andrea, O. Vriz, C. Astarita, E. Bossone, F. Heggemann, T. H. Walter, T. H. Kaelsch, T. Sueselbeck, T. H. Papavassiliu, M. Borggrefe, D. Haghi, T. Monk-Hansen, C. Have Dall, S. Bisgaard Christensen, M. Snoer, F. Gustafsson, H. Rasmusen, E. Prescott, G. Finocchiaro, B. Pinamonti, M. Merlo, G. Barbati, A. Di Lenarda, R. Bussani, G. Sinagra, T. Butz, C. N. Lang, A. Meissner, G. Plehn, H. Yeni, C. Langer, H. J. Trappe, X. Gu, X. Y. Gu, Y. H. He, Z. A. Li, J. C. Han, J. Chen, P. Gaudron, M. Niemann, S. Herrmann, K. Hu, B. Bijnens, H. Hillenbrand, M. Beer, G. Ertl, F. Weidemann, A. Mazzone, M. Mariani, I. Foffa, A. Vianello, S. Del Ry, S. Bevilacqua, M. G. Andreassi, M. Glauber, S. Berti, M. Grabowski, M. Postula, A. Dragulescu, G. Van Arsdell, O. Al-Radi, C. Caldarone, L. Mertens, K. J. Lee, R. P. Casula, H. Yadav, A. Cherian, A. D. Hughes, A. Vitarelli, S. D'orazio, B. L. Nguyen, G. Iorio, D. Battaglia, F. Caranci, V. Padella, L. Capotosto, L. Alessandroni, F. Barilla, C. Cardin, S. Hascoet, M. Saudron, G. Caudron, B. Arnaudis, P. Acar, M. M. Sun, X. H. Shu, C. Z. Pan, X. Y. Fang, D. H. Kong, F. Fang, Q. Zhang, Y. S. Chan, J. M. Xie, W. K. Yip, Y. Y. Lam, J. E. Sanderson, C. M. Yu, M. Rosca, K. O' Connor, G. Romano, J. Magne, A. Calin, D. Muraru, L. Pierard, P. Lancellotti, A. Roushdy, I. Elfiky, G. El Shahid, A. Elfiky, M. El Sayed, K. Wierzbowska-Drabik, L. Chrzanowski, A. Kapusta, E. Plonska-Goscinak, M. Krzeminska-Pakula, M. Kurpesa, T. Rechcinski, E. Trzos, J. D. Kasprzak, M. K. Ersboll, N. Valeur, U. M. Mogensen, M. Andersen, C. Hassager, P. Sogaard, L. V. Kober, M. Kloeckner, D. Hayat, C. Dussault, N. Lellouche, N. Elbaz, A. Demopoulos, G. Hatzigeorgiou, E. Leontiades, A. Motsi, G. Karatasakis, G. Athanassopoulos, P. Zycinski, J. Kasprzak, M. C. Vazquez Alvarez, C. Medrano Lopez, M. Camino Lopez, S. Granja, J. L. Zunzunegui Martinez, E. Maroto Alvaro, W.-C. Tsai, J.-Y. Chen, Y.-W. Liu, C.-C. Lin, L.-M. Tsai, D. C. Gomes, S. Robalo Martins, M. R. Gois, S. Ribeiro, A. Nunes Diogo, P. Sengupta, G. Di Bella, G. Caracciolo, S. Lentini, E. Kinova, N. Zlatareva, A. Goudev, N. Papagiannis, M. Mpouki, A. Papagianni, M. Vorria, G. Mpenetos, D. Lytra, E. Papadopoulou, P. Sgourakis, J. Malakos, J. Kyriazis, V. Kodali, R. Toole, A. S. Gopal, J. Celutkiene, A. Rudys, V. Grabauskiene, S. Glaveckaite, E. Sadauskiene, Z. Lileikiene, N. Bickauskaite, E. Ciburiene, V. Skorniakov, A. Laucevicius, C. H. Attenhofer Jost, M. Pfyffer, R. Lindquist, J. L. F. Santos, O. R. C. Coelho, C. M. Mady, M. H. P. Picard, V. M. C. Salemi, L. Funk, M. W. Prull, J.-Y. Shih, Y.-Y. Huang, K. O'connor, M. Moonen, L. A. Pierard, D. C. Cozma, C. Mornos, A. Ionac, L. Petrescu, D. Dragulescu, R. Dan, I. Popescu, S. I. Dragulescu, T. G. Von Lueder, A. Hodt, G. F. Gjerdalen, T. E. Andersen, E. E. Solberg, K. Steine, T. Van Mieghem, M. Rostek, W. Pikto-Pietkiewicz, M. Dluzniewski, A. Antoniewicz, S. Poletajew, A. Borowka, T. Pasierski, S. K. Malyutina, M. Ryabikov, J. Ragino, A. Ryabikov, S. Sitia, L. Tomasoni, F. Atzeni, L. Gianturco, P. Sarzi-Puttini, V. De Gennaro Colonna, M. Turiel, F. R. Gutierrez, G. Lefhtheriotis, R. T. Hurst, M. R. Nelson, F. Mookadam, V. Thota, U. Emani, M. Al Harthi, J. Stepanek, S. Cha, S. J. Lester, E. M. M. Ho, L. Hemeryck, M. Hall, K. Scott, K. Bennett, A. Mahmud, C. Daly, G. King, R. T. Murphy, A. S. Brown, A. J. Teske, J. D'Hooge, P. Claus, F. Rademakers, L. Santos, N. Cortez-Dias, S. Goncalves, M. Almeida Ribeiro, A. Bordalo E Sa, C. Magnino, P. Marcos-Alberca, A. Milan, C. Almeria, V. Caniadas, J. L. Rodrigo, L. Perez De Isla, J. L. Zamorano, U. Gustafsson, M. Larsson, P. Lindqvist, L. Brodin, A. Waldenstrom, B. Roosens, S. Hernot, S. Droogmans, G. Van Camp, T. Lahoutte, B. Cosyns, C. M. Rao, D. Aguglia, G. Casciola, C. Imbesi, A. Marvelli, M. Sgro, D. Benedetto, R. Tripepi, C. Zoccali, F. A. Benedetto, L. P. Badano, M. Cardillo, L. Del Mestre, P. Gianfagna, A. Proclemer, H. D. Tschernich, B. Mora, E. Base, U. Weber, J. Dumfarth, C. Mukherjee, H. S. Skaltsiotis, A. K. Kaladaridis, D. B. Bramos, G. K. Kottis, A. A. Antoniou, I. A. Agrios, D. T. Takos, N. V. Vasiladiotis, K. P. Pamboucas, S. T. T. Toumanidis, A. Shim, P. Lipec, B. Michalski, B. Wozniakowski, L. Stefanczyk, A. Rotkiewicz, M. Cameli, M. Lisi, M. Padeletti, E. Bigio, S. Bernazzali, C. Tsoulpas, M. Maccherini, M. Henein, S. Mondillo, I. Garcia Lunar, S. Mingo Santos, V. Monivas Palomero, C. Mitroi, P. Beltran Correas, L. Ruiz Bautista, A. Muniz Lozano, M. Gonzalez Gonzalez, B. Stegemann, K. Willson, R. Zeppellini, A. Iavernaro, M. Zadro, M. Carasi, R. De Domenico, T. Rigo, E. Artuso, G. Erente, A. Ramondo, T. T. Le, F. Q. Huang, Y. Gu, and R. S. Tan

Subjects
Cardiac function curve, medicine.medical_specialty, medicine.anatomical_structure, business.industry, Ventricle, Internal medicine, medicine, Cardiology, Radiology, Nuclear Medicine and imaging, General Medicine, Cardiology and Cardiovascular Medicine, Rotation, business
Published
2010
Full Text
View/download PDF

10. Moderated Poster Sessions 3: Right ventricle in normal conditions and under pressure * Friday 9 December 2011, 08:30-12:30 * Location: Moderated Poster Area

Author

M. Galderisi, F. Bauer, D. De Palma, A. Rendon, V. Schiano Lomoriello, V. Hansteen, M. Sitges, M. Azqueta, J. Lopez Ayerbe, A. Dawood, M. Melsom, I. Skjorten, R. Esposito, C. Viacroze, J. Grapsa, M. F. Elnoamany, Nuria Vallejo, R. Raia, A. Zaidi, T. Khalil, B. Bijnens, J. Brugada, N. Sheikh, J. Mykland, Lluís Mont, K. Steine, S. Ghani, A. Santoro, J. Hisdal, F. Gual Capllonch, A. Bayes Genis, R. Palma Reis, G. Hernandez, S. Dominique, T. Osaki, M. Satendra, N. Lousada, T. Ishida, C. Pare, R. Sharma, S. Gati, E. Gomez Denia, D. Dawson, K. Sugi, T. Coulter, R. Howes, Barbara Vidal, Elena Ferrer, S. Sharma, B. Merino Sierra, T. Otsuka, P. Nihoyannopoulos, S. Humerfelt, T. Ono, L. Sargento, B. Smith, W. Gorissen, B. Kurtz, C. Vallet, H. Yoshikawa, G. Hashimoto, M. Elhabeeby, Q. Landolff, M. Yamamoto, Albert Teis, N. Itou, H. Eltchaninoff, X. Yanguas, C. Sousa, R. Ippolito, and M. Suzuki

Subjects
medicine.medical_specialty, business.industry, Diastole, Healthy subjects, General Medicine, Doppler imaging, medicine.anatomical_structure, Ventricle, Internal medicine, cardiovascular system, Tricuspid annulus, Cardiology, Medicine, Radiology, Nuclear Medicine and imaging, Diastolic function, Inflow velocity, Cardiology and Cardiovascular Medicine, business
Abstract

Background: Normative Doppler values and determinants for gender difference of right ventricular diastolic function in healthy subjects have not been fully elucidated. The purpose of this study is to verify the difference of right ventricular diastolic function between men and women at each age. Method: One hundred sixty nine male and 221 female in healthy subject, aged 20 to 90, were examined by both tricuspid inflow velocity and tricuspid annulus velocity by tissue Doppler imaging. All subjects were divided into 7 groups as 20s, 30s, 40s, 50s, 60s, 70s, 80s depend on their age. Results: The tricuspid E velocity was significantly decreased with age (p,0.0001). The tricuspid A velocity was significantly increased with age (p,0.0001). But both E and A velocity were no differences significantly in all generation between men and women (Table). Ratio of tricuspid E and A velocity (E/A) was significantly decreased with age. But no differences were observed in ratio of E/A in all generation between men and women. (20s: 2.0+0.6 vs 2.3+0.6, 30s: 1.9+0.5 vs 2.1+0.5, 40s: 1.6+0.4 vs 1.9+0.5, 50s: 1.3+0.3 vs 1.5+0.4, 60s: 1.2+0.2 vs 1.2+0.3, 70s: 1.1+0.3 vs 1.1+0.3, 80s: 1.2+0.3 vs 1.2+0.3, total: 1.4+0.5 vs 1.5+0.6). Early diastole velocity of tricuspid annulus (Ea) by tissue Doppler method was significantly decreased with age. But Ea was no differences significantly in all generation between men and women (Table). Conclusion: Our results provide the normative Doppler values of right ventricular diastolic function for age decades. There was no difference significantly of right ventricular diastolic function between men and women.

Published
2011
Full Text
View/download PDF

11. Q Fever Endocarditis: A Challenging Diagnosis in a Patient Referring Weight Loss and Anorexia, and With Granulomas in Gastric Biopsy Specimens.

Author

Lago-Rodriguez AE, Fraile-Ribot PA, Amengual-Antich I, Gual-Capllonch F, and Garcia-Gasalla M

Abstract

Diagnosis of Q fever endocarditis is challenging since clinical findings are non-specific and diagnosis is mainly made by indirect methods such as serology. A progressive constitutional syndrome, severe asthenia, anorexia with no fever and histopathological findings of non-necrotizing gastric granulomas in a gastric biopsy were found preceding a cardiac failure in our case report. Prolonged treatment with doxycycline and hydroxychloroquine is mandatory, and cardiac valve surgery may be needed., Competing Interests: The authors declare no conflicts of interest., (© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.)

Published
2024
Full Text
View/download PDF

12. Left atrial strain in patients without cardiovascular disease: uncovering influencing and related factors.

Author

Forteza-Albertí JF, Rico Y, Leiva A, Pericas P, Gual-Capllonch F, Rivas-Catoni L, Gutiérrez García-Moreno L, Rodríguez Fernández A, and Peral Disdier V

Subjects
Humans, Male, Female, Middle Aged, Prospective Studies, Cardiovascular Diseases physiopathology, Cardiovascular Diseases diagnosis, Ventricular Function, Left physiology, Heart Atria physiopathology, Heart Atria diagnostic imaging, Atrial Function, Left physiology, Echocardiography methods, Stroke Volume physiology
Abstract

Background: Despite its proven prognostic value in different contexts, the precise implications of left atrial strain (LAS) assessment throughout different phases of the atrial cycle remain uncertain. A direct correlation between left atrial reservoir strain (LARS) and left ventricular global longitudinal strain (GLS) has been consistently demonstrated in several studies involving patients with various heart diseases. The objective of our study is to identify factors directly associated with LARS, left atrial conduction strain (LACS) and left atrial booster strain (LABS) in patients without cardiovascular (CV) disease., Methods: Transthoracic echocardiographic examinations in patients without CV disease were prospectively selected in two tertiary hospitals echocardiography labs for clinical purposes. LAS, maximal and minimal left atrial (LA) volumes and left atrial ejection fraction (LAEF) were measured using the two-dimensional strain analysis package provided by the EchoPAC Plugging workstation (AFI LA)., Results: A total of 196 cases were included, median age of 54 (45-62) with 85 (43%) being men. The mean left ventricular ejection fraction (LVEF) was 61% ± 5, and the median GLS was - 18% (-17 to -20). Median indexed maximum volume of left atrium (LAVI) was 27 ml/m 2 (22-31), and LAEF was 64% (58-70). The mean LARS biplane was 35,1% ± 8. Notably, LARS was greater in the 2-chamber view (36,1% ± 10) compared to the 4-chamber view (34,1% ± 8 p < 0,05). The multivariate analysis of LARS revealed that sex, GLS, LAEF and e' mean are independently correlated with LARS. Multivariate analysis of LACS showed independent correlations between LACS and age, GLS, LAEF, E/A ratio and e' mean . Conversely, the multivariate analysis of LABS demonstrated significant correlations among A wave, e' mean , and left atrial stiffness index (LASI)., Conclusions: In patients without CV disease, GLS emerges as a crucial determinant of LARS and LACS. LAEF and e' mean are directly and independently related to both LARS and LACS. LARS (univariate) and LACS (multivariate) exhibited a decline with older age in individuals without CV disease., (© 2024. The Author(s).)

Published
2024
Full Text
View/download PDF

13. Diagnosing diastolic dysfunction and heart failure with preserved ejection fraction in patients with atrial fibrillation: a clinical challenge.

Author

Beladan CC, Gual-Capllonch F, Popescu AC, and Popescu BA

Subjects
Humans, Ventricular Dysfunction, Left diagnostic imaging, Ventricular Dysfunction, Left physiopathology, Female, Male, Diastole, Aged, Heart Failure, Diastolic diagnostic imaging, Heart Failure, Diastolic physiopathology, Risk Assessment, Atrial Fibrillation diagnostic imaging, Atrial Fibrillation physiopathology, Atrial Fibrillation complications, Stroke Volume physiology, Echocardiography methods, Heart Failure diagnostic imaging, Heart Failure physiopathology, Heart Failure complications
Abstract

Left ventricular (LV) diastolic dysfunction, atrial fibrillation (AF), and heart failure with preserved ejection fraction (HFpEF) share common risk factors and are closely related to one another and to adverse cardiovascular events. Exertional dyspnoea in patients with AF should trigger a comprehensive LV diastolic function evaluation since AF frequently precedes incident HFpEF. An echocardiographic assessment of LV diastolic function in patients with AF is challenging, mainly because of variability in cycle length, the absence of atrial contraction, and the frequent occurrence of left atrial enlargement regardless of LV filling pressures (LVFPs). The algorithm of the 2016 recommendations for the evaluation of LV diastolic function cannot be directly applied in this setting. This review discusses the modalities available for diastolic function assessment and HFpEF diagnosis in patients with AF. Based on currently available data, a reasonable clinical target of diastolic function evaluation in AF would be to reach a binary conclusion: LVFP elevated or not. Recently, a two-step algorithm that combined several echocardiographic parameters plus the inclusion of body mass index has been proposed to differentiate normal from elevated LVFP in patients with AF. The echocardiographic evaluation must be complemented by a thorough clinical evaluation along with natriuretic peptides and cardiac catheterization in selected cases. If a diagnosis of HFpEF cannot be ascertained, a close follow-up for timely identification of diastolic dysfunction markers, along with monitoring and correction of modifiable risk factors, is recommended., Competing Interests: Conflict of interest: B.A.P. has received research support and speaker honoraria from GE Healthcare. C.C.B. has received speaker honoraria from GE Healthcare. A.C.P. and F.G.C. report no conflicts., (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)

Published
2024
Full Text
View/download PDF

14. Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment.

Author

Lorenzo-Esteller L, Ramos-Polo R, Pons Riverola A, Morillas H, Berdejo J, Pernas S, Pomares H, Asiain L, Garay A, Martínez Pérez E, Jiménez-Marrero S, Alcoberro L, Nadal E, Gubern-Prieto P, Gual-Capllonch F, Hidalgo E, Enjuanes C, Comin-Colet J, and Moliner P

Abstract

Pericardial disease is increasingly recognized in cancer patients, including acute pericarditis, pericardial effusion, and constrictive pericarditis, often indicating a poor prognosis. Acute pericarditis arises from direct tumor involvement, cancer therapies, and radiotherapy. Immune checkpoint inhibitor (ICI)-related pericarditis, though rare, entails significant mortality risk. Treatment includes NSAIDs, colchicine, and corticosteroids or anti-IL1 drugs in refractory cases. Pericardial effusion is the most frequent manifestation, primarily caused by lung cancer, followed by breast cancer, lymphoma, leukemia, gastrointestinal tumors, and melanoma. Chemotherapy, immunotherapy, and radiotherapy may also cause fluid accumulation in the pericardial space. Symptomatic relief for pericardial effusion may require pericardiocentesis, prolonged catheter drainage, or a pericardial window. Instillation of intrapericardial cytostatic agents may reduce recurrence. Constrictive pericarditis, though less common, often develops from radiotherapy and requires multimodality imaging for diagnosis, with pericardiectomy as the definitive treatment. Primary pericardial tumors are rare, with metastases being more frequent. Patients with cancer and pericardial disease generally have poor survival, emphasizing the need for early detection. A multidisciplinary approach involving hematologists, oncologists, and cardiologists is crucial to tailoring pericardial disease treatment to a patient's clinical status, thereby improving the quality of life and prognosis.

Published
2024
Full Text
View/download PDF

17. Atrial Mitral and Tricuspid Regurgitation: Sex Matters. A Call for Action to Unravel the Differences Between Women and Men.

Author

Gual-Capllonch F, Sáenz de Ibarra JI, Bayés-Genís A, and Delgado V

Abstract

Atrial functional regurgitation is caused by atrioventricular annulus dilation, with normal leaflets and ventricular dimensions and function within the normal range. Its occurrence, in both mitral and tricuspid valves, implies a worse prognosis due to the hemodynamic derangement they produce, but also constitutes a marker of greater comorbidity and more advanced disease. Predisposing conditions for these heart valve dysfunctions are mainly atrial fibrillation and heart failure with preserved ejection fraction. However, other factors like female sex also may be involved and influence their incidence, especially for atrial tricuspid regurgitation. In the present review, we analyze sex differences in the reported prevalence of atrial mitral and tricuspid regurgitation, and suggest possible mechanisms involved. Finally, we underline potential therapeutic and preventive strategies to reduce the burden of these heart valve disorders and discuss research gaps., Competing Interests: VD received speaker fees from Abbott Vascular, Edwards Lifesciences, GE healthcare, Medtronic, MSD and Novartis. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Gual-Capllonch, Sáenz de Ibarra, Bayés-Genís and Delgado.)

Published
2022
Full Text
View/download PDF

19. Prevalence and factors associated with atrial mitral and tricuspid regurgitation in patients with atrial fibrillation.

Author

Gual-Capllonch F, Cediel G, Teis A, Ferrer-Sistach E, Borrellas A, Juncà G, Vallejo N, López-Ayerbe J, Kasa Pla-Esperanzi G, and Bayes-Genis A

Subjects
Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Heart Atria diagnostic imaging, Humans, Male, Prevalence, Atrial Fibrillation complications, Atrial Fibrillation epidemiology, Tricuspid Valve Insufficiency diagnostic imaging, Tricuspid Valve Insufficiency epidemiology
Abstract

Background: This study aimed to examine the prevalence of atrial tricuspid regurgitation (ATR) and atrial mitral regurgitation (AMR) in the setting of atrial fibrillation (AFib) and identify variables related to the severity of both types of regurgitation., Methods: Cross-sectional study evaluating data from transthoracic echocardiograms performed during 2019. We included patients with AFib during the examination, and without primary valve disease or other significant heart disease., Results: Four-hundred and thirty-two patients fulfilled the inclusion criteria (mean age 77.5±9.2 years, 49.1% women). We observed significant ATR in 14.8%, and significant AMR in 1.4% of patients. ATR and AMR severities were equal in 49.3% of patients, and 41% displayed greater ATR severity. ATR prevalence was significantly greater among women (23.1% vs 6.8%, p < 0.001), but AMR prevalence was similar between genders (1.9% vs .9%, p = 0.443). Variables related to greater ATR severity were: female sex (OR: 2.61, 95%CI: 1.60-4.24), left atrial (LA) volume (OR: 3.58, 95%CI: 1.50-8.55), systolic pulmonary artery pressure (OR: 1.10, 95%CI: 1.07-1.13), and moderate AMR (OR: 2.21, 95%CI: 1.22-4.00). Variables related to greater AMR severity were female sex (OR: 1.96, 95%CI: 1.24-3.09), LA volume (OR: 11.68, 95%CI: 5.29-25.80), and body mass index (OR: .94, 95%CI: .90-.98)., Conclusions: In the context of AFib, ATR was more prevalent than AMR and prevailed in women. LA enlargement was associated with higher degrees of both AMR and ATR. Pulmonary hypertension was also independently associated with ATR, as well as greater AMR severity, suggesting possible adaptive changes in leaflets that might modify the atrial regurgitation incidence., (© 2021 Wiley Periodicals LLC.)

Published
2021
Full Text
View/download PDF

20. Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation.

Author

Abdul-Jawad Altisent O, Benetis R, Rumbinaite E, Mizarien V, Codina P, Gual-Capllonch F, Spitaleri G, Fernandez-Nofrerias E, Bayes-Genis A, and Puri R

Abstract

Severe tricuspid regurgitation remains a challenging heart-valve disease to effectively treat with high morbidity and mortality at mid-term. Currently guideline-directed medical treatment is limited to escalating dose of diuretics, and the rationale and timing of open-heart surgery remains controversial. Emerging percutaneous therapies for severe tricuspid regurgitation continue to show promising results in early feasibility studies. However, randomized trial data is lacking. Additionally, many patients are deemed unsuitable for these emerging therapies due to anatomical or imaging constraints. Given the technical simplicity of the bicaval valve implantation (CAVI) technique compared to other transcatheter devices, CAVI is postulated as a suitable alternative for a wide variety of patients affected with severe+ tricuspid regurgitation. In this review we illustrate the current evidence and ongoing uncertainties of CAVI, focusing on the novel CAVI-specific devices.

Published
2021
Full Text
View/download PDF

21. Preload dependence of pulmonary haemodynamics and right ventricular performance.

Author

Gual-Capllonch F, Lupón J, Bancu I, Graterol F, Ferrer-Sistach E, Teis A, Santiago-Vacas E, Vallejo N, Juncà G, and Bayes-Genis A

Subjects
Echocardiography, Doppler methods, Female, Heart Ventricles diagnostic imaging, Hemodynamics physiology, Humans, Hypertension, Pulmonary, Male, Middle Aged, Prospective Studies, Systole, Heart Ventricles physiopathology, Pulmonary Artery physiopathology, Vascular Resistance physiology, Ventricular Function, Left physiology, Ventricular Function, Right physiology
Abstract

Aims: Systolic pulmonary artery pressure (SPAP) and right heart adaptation in relation to pre-existing preload are often disregarded. To determine volume-related changes in the pulmonary-right ventricle (RV) unit and the preload dependence of its components, we analysed pulmonary haemodynamics and right ventricular performance, taking advantage of the plasma volume removal associated to haemodialysis (HD)., Methods and Results: Fifty-three stable patients on chronic HD with LVEF > 50% and without heart failure were recruited (mean age 63.0 ± 12.4 years; 31.2% women; hypertension in 89% and diabetes in 53%) and evaluated just before and after HD (mean ultrafiltration volume 2.4 ± 0.7 l). SPAP from both times were available in 39 patients. After HD, SPAP decreased (42.2 ± 12.6 to 33.7 ± 11.6 mmHg, p < 0.001) without modification of non-invasive pulmonary vascular resistance (1.75 ± 0.44 to 1.75 ± 0.40 eWU, p = 0.94). Age and drop in the E/e' ratio were the variables associated with greater reduction in PASP (p = 0.022 and p = 0.049, respectively). A significant reduction of right chamber sizes was observed, along with a diminution in measures of RV contractility, excluding RV longitudinal strain. Functional tricuspid regurgitation (FTR) diminution was observed in 26% of patients, occurring in every case with more than mild FTR. On multivariate analyses, left atrial size was the only predictor of pulmonary hypertension (defined as SPAP > 40 mmHg) (OR 1.29 (1.07-1.56), p = 0.006)., Conclusion: Rapid volemic changes may affect FTR grading, RV size and contractility, with RV longitudinal strain being less variable than conventional parameters. SPAP decreases after HD, and this reduction is related to age and greater diminution of the E/e' ratio.

Published
2021
Full Text
View/download PDF

22. Particle size and cholesterol content of circulating HDL correlate with cardiovascular death in chronic heart failure.

Author

Teis A, Cediel G, Amigó N, Julve J, Aranyó J, Andrés-Cordón J, Puig-Jové C, Castelblanco E, Gual-Capllonch F, Ferrer-Sistach E, Vallejo N, Juncà G, López-Ayerbe J, De Antonio M, Domingo M, Santiago-Vacas E, Codina P, Mauricio D, Lupón J, Alonso N, and Bayes-Genis A

Subjects
Aged, Aged, 80 and over, Biomarkers blood, Biomarkers chemistry, Cardiovascular System metabolism, Cardiovascular System physiopathology, Cholesterol, HDL chemistry, Chronic Disease, Cohort Studies, Female, Heart Failure mortality, Heart Failure physiopathology, Humans, Magnetic Resonance Spectroscopy, Male, Middle Aged, Multivariate Analysis, Outpatients, Prognosis, Survival Analysis, Cholesterol, HDL blood, Heart Failure blood, Heart Failure diagnosis, Particle Size
Abstract

Evidence regarding any association of HDL-particle (HDL-P) derangements and HDL-cholesterol content with cardiovascular (CV) death in chronic heart failure (HF) is lacking. To investigate the prognostic value of HDL-P size (HDL-Sz) and the number of cholesterol molecules per HDL-P for CV death in HF patients. Outpatient chronic HF patients were enrolled. Baseline HDL-P number, subfractions and HDL-Sz were measured using 1H-NMR spectroscopy. The HDL-C/P ratio was calculated as HDL-cholesterol over HDL-P. Endpoint was CV death, with non-CV death as the competing event. 422 patients were included and followed-up during a median of 4.1 (0-8) years. CV death occurred in 120 (30.5%) patients. Mean HDL-Sz was higher in CV dead as compared with survivors (8.39 nm vs. 8.31 nm, p < 0.001). This change in size was due to a reduction in the percentage of small HDL-P (54.6% vs. 60% for CV-death vs. alive; p < 0.001). HDL-C/P ratio was higher in the CV-death group (51.0 vs. 48.3, p < 0.001). HDL-Sz and HDL-C/P ratio were significantly associated with CV death after multivariable regression analysis (HR 1.22 [95% CI 1.01-1.47], p = 0.041 and HR 1.04 [95% CI 1.01-1.07], p = 0.008 respectively). HDL-Sz and HDL-C/P ratio are independent predictors of CV death in chronic HF patients.

Published
2021
Full Text
View/download PDF

23. R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.

Author

Sancho JM, Fernández-Alvarez R, Gual-Capllonch F, González-García E, Grande C, Gutiérrez N, Peñarrubia MJ, Batlle-López A, González-Barca E, Guinea JM, Gimeno E, Peñalver FJ, Fuertes M, Bastos M, Hernández-Rivas JÁ, Moraleda JM, García O, Sorigué M, and Martin A

Subjects
Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Cyclophosphamide administration & dosage, Doxorubicin administration & dosage, Female, Humans, Lymphoma, Large B-Cell, Diffuse pathology, Male, Middle Aged, Prednisone administration & dosage, Prospective Studies, Retrospective Studies, Rituximab administration & dosage, Treatment Outcome, Vincristine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lymphoma, Large B-Cell, Diffuse drug therapy, Ventricular Function, Left drug effects
Abstract

The use of non-pegylated liposomal doxorubicin (Myocet ® ) in diffuse large B-cell lymphoma (DLBCL) has been investigated in retrospective and single-arm prospective studies. This was a prospective phase 2 trial of DLBCL patients ≥60 years old with left ventricular ejection fraction (LVEF) ≥55% randomized to standard R-CHOP or investigational R-COMP (with Myocet ® instead of conventional doxorubicin). The primary end point was to evaluate the differences in subclinical cardiotoxicity, defined as decrease in LVEF to <55% at the end of treatment. Secondary objectives were efficacy, safety, and variations of troponin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and LVEF along follow-up. Ninety patients were included, 45 in each group. No differences were observed in the percentage of patients with LVEF <55% at end of treatment (11% in R-CHOP arm vs. 7% in R-COMP arm, p = 0.697) or at 4 months (10% vs. 6%, respectively, p = 0.667) and 12 months (8% vs. 7%, respectively, p = 1). However, a higher percentage of R-CHOP compared with R-COMP patients showed increased troponin levels in cycle 6 (100% vs. 63%, p = 0.001) and at 1 month after treatment (88% vs. 56%, respectively, p = 0.015). Cardiovascular adverse events were seen in five R-CHOP patients (nine episodes, four grade ≥3) and in four R-COMP patients (five episodes, all grade 1-2). No significant differences in efficacy were observed. In conclusion, R-COMP is a feasible immunochemotherapy schedule for DLBCL patients ≥60 years, with similar efficacy to R-CHOP. However, the use of non-pegylated doxorubicin instead of conventional doxorubicin was not associated with less early cardiotoxicity, although some reduced cardiac safety signals were observed. Trial registration: ClinicalTrials.gov Identifier: NCT02012088., (© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)

Published
2021
Full Text
View/download PDF

24. Sex-Related Differences in the Mechanism of Functional Tricuspid Regurgitation.

Author

Gual-Capllonch F, Cediel G, Ferrer E, Teis A, Juncà G, Vallejo N, López-Ayerbe J, and Bayes-Genis A

Subjects
Aged, Echocardiography methods, Female, Follow-Up Studies, Humans, Male, Prospective Studies, Sex Factors, Tricuspid Valve Insufficiency diagnosis, Stroke Volume physiology, Tricuspid Valve Insufficiency physiopathology, Ventricular Function, Left physiology
Abstract

Background: Predictive factors of significant functional tricuspid regurgitation (FTR) are not completely understood. We investigated sex-related differences in predictors of FTR progression., Method: Clinical and echocardiographic variables were recorded in a prospective single-centre observational cohort of 251 consecutive stable patients with FTR. Multivariable logistic regression analyses stratified by sex were performed to identify predictors of significant FTR., Results: The mean age of the whole cohort was 72.2±11.4 years, and 133 (53%) patients were women. Females tended to have a higher prevalence of significant FTR (22.6% vs 13.6%; p=0.066). Women were also older than men (mean age 74.4 vs 69.6 years; p<0.001), with more frequent history of arterial hypertension, worse New York Heart Association functional class, higher E/e' quotient, and higher left ventricular ejection fraction. The independent predictors of significant FTR in women were atrial fibrillation (AF) (odds ratio [OR] 10.8, 95% confidence interval [CI] 2.9-40.7; p<0.001), indexed tricuspid diameter annulus (OR 1.24, 95% CI 1.04-1.47; p=0.017), and pulmonary artery systolic pressure (PASP) (OR 1.09, 95% CI 1.04-1.15; p=0.001). The independent predictors of outcome in men were indexed tricuspid tenting height (OR 2.71, 95% CI 1.20-6.11; p=0.016), indexed tricuspid diameter annulus (OR 1.98, 95% CI 1.26-3.09; p=0.003), and PASP (OR 1.08, 95% CI 1.01-1.16; p=0.021)., Conclusions: The presence of AF and longer indexed tenting height convey a greater risk of significant FTR in females and males, respectively. These findings suggest the existence of different physiopathological mechanisms involved in the progression of FTR in both sexes., (Copyright © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.)

Published
2021
Full Text
View/download PDF

25. Pulmonary hypertension and right ventricular dysfunction in heart failure: prognosis and 15-year prospective longitudinal trajectories in survivors.

Author

Santiago-Vacas E, Lupón J, Gavidia-Bovadilla G, Gual-Capllonch F, de Antonio M, Domingo M, Núñez J, Zamora E, Teis A, Moliner P, Codina P, Santesmases J, and Bayes-Genis A

Subjects
Humans, Prognosis, Prospective Studies, Survivors, Ventricular Function, Right, Heart Failure epidemiology, Hypertension, Pulmonary diagnosis, Hypertension, Pulmonary epidemiology, Ventricular Dysfunction, Right diagnostic imaging, Ventricular Dysfunction, Right epidemiology
Abstract

Aims: Systolic pulmonary artery pressure (SPAP), tricuspid annular plane systolic excursion (TAPSE), and TAPSE/SPAP ratio trajectories are not fully characterized in chronic heart failure (HF). We assessed very long-term longitudinal SPAP, TAPSE and TAPSE/SPAP trajectories in HF patients, and their dynamic changes in outcomes., Methods and Results: Prospective, consecutive, observational registry of real-life HF patients, performing echocardiography studies at baseline and according to a prospectively structured schedule after 1 year, and then every 2 years, up to 15 years. Pulmonary hypertension (PH) was defined as SPAP ≥40 mmHg; right ventricular dysfunction (RVD) was defined at TAPSE ≤16 mm; and TAPSE/SPAP ratio was dichotomized at 0.36 mm/mmHg. The clinical endpoints were all-cause death, the composite endpoint of mortality or HF hospitalization and the number of recurrent HF hospitalizations. The study cohort included 1557 patients. Long-term SPAP trajectory Loess curves were U-shaped with a nadir at 7 years. TAPSE Loess curves showed a marked rise during the first year, with stabilization thereafter. TAPSE/SPAP ratio Loess splines were similar to the later with a smooth decline towards the end. Patients who died had higher SPAP, lower TAPSE and lower TAPSE/SPAP ratio in the preceding period than survivors. Baseline PH and/or RVD were independently associated with mortality and HF-related hospitalizations, and the persistence of one or both entities at 1 year conferred a worse long-term prognosis., Conclusions: Long-term trajectories for SPAP, TAPSE and TAPSE/SPAP ratio are reported in patients with chronic HF. An increasing SPAP and declining TAPSE and TAPSE/SPAP ratio in the preceding period is associated with higher mortality., (© 2020 European Society of Cardiology.)

Published
2020
Full Text
View/download PDF

26. Secondary prophylaxis of an acute coronary syndrome during rituximab infusion.

Author

Triguero Moreno A, Gual Capllonch F, and Sancho Cía JM

Subjects
Acute Coronary Syndrome chemically induced, Aged, Antineoplastic Agents, Immunological administration & dosage, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Antineoplastic Combined Chemotherapy Protocols adverse effects, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cardiovascular Agents therapeutic use, Clopidogrel therapeutic use, Cyclophosphamide administration & dosage, Diltiazem therapeutic use, Doxorubicin administration & dosage, Female, Humans, Lymphoma, Follicular pathology, Platelet Aggregation Inhibitors therapeutic use, Prednisone administration & dosage, Rituximab administration & dosage, Vincristine administration & dosage, Acute Coronary Syndrome prevention & control, Antineoplastic Agents, Immunological adverse effects, Lymphoma, Follicular drug therapy, Rituximab adverse effects, Secondary Prevention
Published
2020
Full Text
View/download PDF

27. Repeat physical stress echocardiography in asymptomatic severe aortic stenosis.

Author

Ferrer-Sistach E, Lupón J, Serrano García S, Teis Soley A, Gual-Capllonch F, Juncà-Puig G, Vallejo-Camazón N, López-Ayerbe J, and Bayés-Genís A

Subjects
Aged, Aged, 80 and over, Aortic Valve physiopathology, Aortic Valve surgery, Aortic Valve Stenosis physiopathology, Aortic Valve Stenosis surgery, Asymptomatic Diseases, Clinical Decision-Making, Female, Heart Valve Prosthesis Implantation, Humans, Male, Predictive Value of Tests, Prospective Studies, Severity of Illness Index, Time Factors, Aortic Valve diagnostic imaging, Aortic Valve Stenosis diagnostic imaging, Echocardiography, Stress, Exercise Test
Published
2020
Full Text
View/download PDF

28. Thromboembolism and bleeding in patients with cancer and mechanical heart valves.

Author

Plaja A, Berastegui E, Nieto-Moragas J, Sarrate E, Gual-Capllonch F, Quiroga V, and Sorigue M

Subjects
Aged, Anticoagulants adverse effects, Case-Control Studies, Female, Follow-Up Studies, Heart Valve Prosthesis Implantation adverse effects, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Surgical Procedures, Operative adverse effects, Vitamin K antagonists & inhibitors, Heart Valve Prosthesis adverse effects, Hemorrhage etiology, Neoplasms complications, Thromboembolism etiology
Abstract

Mechanical heart valves (MHV) require life-long anticoagulation with vitamin K antagonists (VKA), but anticoagulation management is complex in patients with cancer due to a high risk of thrombosis and bleeding. This is a retrospective, single-center study to assess anticoagulation management and thrombotic (stroke/valve thrombosis) and bleeding events in patients with active cancer and MHV. The incidence of thrombotic complications was compared to a control group (matched 1:1) of patients with MHV but without cancer. We included 48 patients, 60% of whom had aortic prostheses, 23% mitral prostheses and 17% both types. All patients received VKA as anticoagulant. With a median follow-up of 5.12 years, we observed two arterial thrombotic events (two strokes and no heart valve thrombosis). The 5-year incidence (95% confidence interval [CI]) of stroke/valve thrombosis was 5.7% (0.9-17.9%). The control group had a similar incidence of stroke/valve thrombosis (5-year incidence 7.9% [95%CI 2-19.8], p = 0.16). There were also 15 major bleeding episodes in the cancer group, 11 of which were related to a surgical procedure. The 5-year incidence (95% CI) of major bleeding was 32.9% (18.5-48%), and that of major bleeding unrelated to any procedure was 10.3% (3-23%). We found a low incidence of thrombotic events in this series of patients with active cancer and MHV who were anticoagulated with VKA. However, the incidence of bleeding was high, particularly in relation to invasive procedures.

Published
2019
Full Text
View/download PDF

29. Starting anticoagulation with vitamin k antagonists alone or with concomitant low-molecular weight heparin for non-valvular atrial fibrillation.

Author

Sarrate E, Gual-Capllonch F, and Sorigue M

Subjects
Administration, Oral, Aged, Aged, 80 and over, Blood Coagulation, Drug Therapy, Combination, Humans, Practice Patterns, Physicians', Stroke prevention & control, Anticoagulants therapeutic use, Atrial Fibrillation drug therapy, Heparin, Low-Molecular-Weight therapeutic use, Stroke epidemiology, Vitamin K antagonists & inhibitors
Published
2019
Full Text
View/download PDF

30. Pulmonary vascular resistance versus pulmonary artery pressure for predicting right ventricular remodeling and functional tricuspid regurgitation.

Author

Gual-Capllonch F, Teis A, Ferrer E, Núñez J, Vallejo N, Juncà G, López-Ayerbe J, Lupón J, and Bayes-Genis A

Subjects
Aged, Female, Heart Ventricles, Humans, Male, Prospective Studies, Pulmonary Artery diagnostic imaging, Severity of Illness Index, Tricuspid Valve Insufficiency diagnostic imaging, Arterial Pressure physiology, Echocardiography methods, Pulmonary Artery physiopathology, Tricuspid Valve Insufficiency physiopathology, Vascular Resistance physiology, Ventricular Remodeling physiology
Abstract

Background: Pulmonary hypertension (PH) is a common cause of right ventricular (RV) remodeling and functional tricuspid regurgitation (FTR), but incremental pulmonary artery systolic pressure (PASP) does not always correlate with anatomic and functional RV changes. This study aimed to evaluate a noninvasive measure of pulmonary vascular resistance (PVR) for predicting RV dilatation, RV dysfunction, and severity of FTR., Methods: We prospectively analyzed consecutive stable patients with PASP ≥ 35 mm Hg or any degree of RV dilatation or dysfunction secondary to PH. Noninvasive PVR was calculated based on FTR peak velocity and flow in RV outflow tract., Results: We included 251 patients, aged 72.1 ± 11.4 years, 53% women, 74.9% with type 2 pulmonary hypertension. The mean PASP was 48.3 ± 12.2 mm Hg. Both PASP and PVR significantly correlated with FTR, RV dilatation, and RV systolic dysfunction. After dichotomizing FTR and RV dilatation and systolic dysfunction as nonsignificant vs significant, FTR and RV dilatation were similarly predicted by PASP and PVR, but RV dysfunction was better predicted by PVR (AUC = 0.78 [0.72-0.84] vs 0.66 [0.60-0.73] for PASP, P < 0.001). Patients with low PASP but high PVR showed worse RV and left ventricular function but lower rates of right heart failure and smaller inferior vena cava, compared to patients with high PASP but low PVR., Conclusions: Noninvasive PVR was superior to PASP for predicting RV systolic dysfunction, but both were similarly associated with RV dilatation or FTR grade. PASP and PVR complement each other to define the echocardiographic findings and clinical status of the patient., (© 2018 Wiley Periodicals, Inc.)

Published
2018
Full Text
View/download PDF

31. Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma.

Author

Sorigue M, Gual-Capllonch F, Garcia O, Sarrate E, Franch-Sarto M, Ibarra G, Grau J, Orna E, Ribera JM, and Sancho JM

Subjects
Aged, Aged, 80 and over, Atrial Fibrillation complications, Atrial Fibrillation diagnosis, Comorbidity, Female, Humans, Incidence, Lymphoma, Non-Hodgkin complications, Lymphoma, Non-Hodgkin diagnosis, Male, Middle Aged, Prognosis, Retrospective Studies, Risk Factors, Survival Analysis, Atrial Fibrillation epidemiology, Atrial Fibrillation therapy, Lymphoma, Non-Hodgkin epidemiology, Lymphoma, Non-Hodgkin therapy
Abstract

Atrial fibrillation (AF) and cancer are common disorders in the general population but there are few studies in patients with both diseases. More specifically, there are scarce data on AF in patients with non-Hodgkin lymphoma (NHL). We assessed the incidence, predictive factors, management, and survival impact of AF in a cohort of patients with NHL from a single institution between 2002 and 2016 (n = 747). Twenty-three patients were diagnosed with AF before and 40 after the diagnosis of NHL (of the later, 16 were secondary to an extracardiac comorbidity and 24 unrelated to any triggering event [primary AF]). The 5-year cumulative incidence of new-onset AF was 4% (95% confidence interval [CI] 3-6%). Age and hypertension were the only predictive factors for the development of AF. Management of AF was heterogeneous, primarily with anti-vitamin K agents but also antiplatelet therapy in a significant proportion of patients. Among the 63 patients, there were six episodes of ischemic stroke/transient ischemic attack and four venous thromboembolic events, with four major bleeding episodes. Overall survival (OS) was inferior in patients with AF (HR 0.1, 95% CI 0.01-0.7, p = 0.02), largely due to secondary AF. We conclude that the incidence of new-onset AF in NHL patients seemed somewhat higher than in the general population, although with similar predictive factors. The management was heterogeneous, and the risk of ischemic and hemorrhagic events did not seem higher than in cancer-free patients. Survival was particularly poor for patients with secondary AF.

Published
2018
Full Text
View/download PDF

32. Evolutive echocardiographic changes in cardiac amyloidosis: Look at the whole picture.

Author

Gual-Capllonch F, Teis A, Ferrer E, and Bayes-Genis A

Subjects
Amyloidosis complications, Amyloidosis physiopathology, Cardiomyopathies complications, Cardiomyopathies physiopathology, Humans, Male, Middle Aged, Ventricular Outflow Obstruction etiology, Ventricular Outflow Obstruction physiopathology, Amyloidosis diagnosis, Cardiomyopathies diagnosis, Echocardiography, Doppler methods, Ventricular Function, Left physiology, Ventricular Outflow Obstruction diagnosis
Abstract

Doppler echocardiogram provides not only structural information about heart chambers, valves and pericardium but also contributes to functional assessment. A unique feature of this assessment is its variability, not only due to heart disease course but also related to extracardiac conditions. We present a case of primary amyloidosis with two atypical characteristics: left ventricular outflow obstruction and low-grade diastolic dysfunction. Nevertheless, a more typical picture of cardiac amyloidosis was observed in the evolution of the disease coinciding with a second cardiac stressor, emphasizing the necessity of not focusing our attention exclusively to the heart., (© 2018 Wiley Periodicals, Inc.)

Published
2018
Full Text
View/download PDF

34. Pulmonary vein spontaneous echocontrast and stroke after pulmonary lobectomy.

Author

Gual-Capllonch F, Teis A, and Palomeras E

Subjects
Aged, Humans, Male, Coronary Thrombosis complications, Coronary Thrombosis diagnostic imaging, Echocardiography, Transesophageal, Intracranial Embolism diagnostic imaging, Intracranial Embolism etiology, Pneumonectomy, Pulmonary Veins diagnostic imaging, Stroke diagnostic imaging, Stroke etiology
Abstract

Assessment of possible cardiac sources of cerebral embolism is a frequent indication for transesophageal echocardiography. We report the case of a patient with a previous left upper pulmonary lobe resection who presented with an ischemic stroke suggestive of cardioembolic origin. A dense spontaneous echo contrast was found in the left upper pulmonary vein stump, which, in the absence of other potential causes of stroke, was considered to be related to the embolic event. We discuss the clinical significance of this finding as a possibly underappreciated source of systemic embolization., (Copyright © 2012 Wiley Periodicals, Inc.)

Published
2013
Full Text
View/download PDF

35. Left atrial intramural haematoma associated with mitral annular calcification.

Author

Gual-Capllonch F, Arce J, Serés L, Vallejo N, Ferrer E, Fernández C, López-Ayerbe J, and Teis A

Subjects
Calcinosis diagnostic imaging, Calcinosis surgery, Chest Pain, Echocardiography, Echocardiography, Transesophageal, Heart Atria diagnostic imaging, Heart Atria surgery, Hematoma diagnostic imaging, Hematoma surgery, Humans, Magnetic Resonance Imaging, Cine, Male, Middle Aged, Mitral Valve diagnostic imaging, Mitral Valve surgery, Time Factors, Calcinosis pathology, Heart Atria pathology, Hematoma pathology, Mitral Valve pathology
Abstract

Left atrial wall haematoma is a very uncommon entity, associated mainly to cardiac surgery, interventional procedures, or trauma. Spontaneous cases are supposed to be associated with left atrial wall pathology. We present a case of a 53-year-old male who was admitted for prolonged chest pain, with transthoracic and transesophagic echocardiography documentation of a left atrial mass in close proximity to a mitral annular calcification. Tissue characterization with cardiac magnetic resonance suggested the aetiology of the mass, which was confirmed histologically.

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results